US20180065914A1 - Ruthenium polymerisation catalysts - Google Patents
Ruthenium polymerisation catalysts Download PDFInfo
- Publication number
- US20180065914A1 US20180065914A1 US15/809,205 US201715809205A US2018065914A1 US 20180065914 A1 US20180065914 A1 US 20180065914A1 US 201715809205 A US201715809205 A US 201715809205A US 2018065914 A1 US2018065914 A1 US 2018065914A1
- Authority
- US
- United States
- Prior art keywords
- group
- groups
- substituted
- fused
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003054 catalyst Substances 0.000 title claims abstract description 72
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 title claims description 15
- 229910052707 ruthenium Inorganic materials 0.000 title claims description 14
- 239000003446 ligand Substances 0.000 claims abstract description 57
- 238000007152 ring opening metathesis polymerisation reaction Methods 0.000 claims abstract description 22
- 125000000129 anionic group Chemical group 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims description 41
- ADLVDYMTBOSDFE-UHFFFAOYSA-N 5-chloro-6-nitroisoindole-1,3-dione Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC2=C1C(=O)NC2=O ADLVDYMTBOSDFE-UHFFFAOYSA-N 0.000 claims description 35
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 30
- -1 C1-C20 carboxylate Chemical group 0.000 claims description 29
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 26
- 125000003118 aryl group Chemical group 0.000 claims description 26
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims description 22
- 239000000178 monomer Substances 0.000 claims description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 13
- 230000000269 nucleophilic effect Effects 0.000 claims description 12
- 238000005649 metathesis reaction Methods 0.000 claims description 11
- 150000001336 alkenes Chemical class 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 8
- 125000001072 heteroaryl group Chemical group 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 7
- 239000012327 Ruthenium complex Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 125000004122 cyclic group Chemical group 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 2
- PXACTUVBBMDKRW-UHFFFAOYSA-M 4-bromobenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=C(Br)C=C1 PXACTUVBBMDKRW-UHFFFAOYSA-M 0.000 claims description 2
- 125000003860 C1-C20 alkoxy group Chemical group 0.000 claims description 2
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 claims description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 2
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 2
- 150000007942 carboxylates Chemical class 0.000 claims description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 2
- 229940049953 phenylacetate Drugs 0.000 claims description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims description 2
- 229950010765 pivalate Drugs 0.000 claims description 2
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 claims description 2
- 125000002577 pseudohalo group Chemical group 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims description 2
- 125000002355 alkine group Chemical group 0.000 claims 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 229920001153 Polydicyclopentadiene Polymers 0.000 abstract description 8
- 125000002091 cationic group Chemical group 0.000 abstract description 4
- 229920000642 polymer Polymers 0.000 abstract description 4
- 150000003303 ruthenium Chemical class 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 description 68
- BFAKENXZKHGIGE-UHFFFAOYSA-N bis(2,3,5,6-tetrafluoro-4-iodophenyl)diazene Chemical compound FC1=C(C(=C(C(=C1F)I)F)F)N=NC1=C(C(=C(C(=C1F)F)I)F)F BFAKENXZKHGIGE-UHFFFAOYSA-N 0.000 description 54
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 46
- 0 *C=[Ru]12(Cl[Ru]3(=C*)(Cl1)[PH](C(C)(C)C)(C(C)(C)C)C[PH]3(C(C)(C)C)C(C)(C)C)[PH](C(C)(C)C)(C(C)(C)C)C[PH]2(C(C)(C)C)C(C)(C)C.*[Ru](Cl)(Cl)=CP[3*].C#N.C#N.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)[C+]2[Ru-](/N=C/C(C)(C)C)(/N=C/C(C)(C)C)(OCOC(F)(F)F)(C(C)(C)C)C(C)(C)C)C(C)=C1.C[Ru](C)(Cl)OCCCc1ccccc1.Cc1ccc(C(C)C)cc1.Cl[Ru+](=C=C=C(C1=CC=CC=C1)C1=CC=CC=C1)[P-](C1CCCCC1)(C1CCCCC1)C1CCCCC1.FB(F)F.F[P-](F)(F)(F)(F)F.O=C([O-])C(F)(F)F.[F-] Chemical compound *C=[Ru]12(Cl[Ru]3(=C*)(Cl1)[PH](C(C)(C)C)(C(C)(C)C)C[PH]3(C(C)(C)C)C(C)(C)C)[PH](C(C)(C)C)(C(C)(C)C)C[PH]2(C(C)(C)C)C(C)(C)C.*[Ru](Cl)(Cl)=CP[3*].C#N.C#N.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)[C+]2[Ru-](/N=C/C(C)(C)C)(/N=C/C(C)(C)C)(OCOC(F)(F)F)(C(C)(C)C)C(C)(C)C)C(C)=C1.C[Ru](C)(Cl)OCCCc1ccccc1.Cc1ccc(C(C)C)cc1.Cl[Ru+](=C=C=C(C1=CC=CC=C1)C1=CC=CC=C1)[P-](C1CCCCC1)(C1CCCCC1)C1CCCCC1.FB(F)F.F[P-](F)(F)(F)(F)F.O=C([O-])C(F)(F)F.[F-] 0.000 description 40
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 37
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-DICFDUPASA-N dichloromethane-d2 Chemical compound [2H]C([2H])(Cl)Cl YMWUJEATGCHHMB-DICFDUPASA-N 0.000 description 28
- 238000006798 ring closing metathesis reaction Methods 0.000 description 28
- 239000000047 product Substances 0.000 description 25
- 239000000758 substrate Substances 0.000 description 21
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- VRBHURBJIHILRI-UHFFFAOYSA-N 1H-inden-1-ylidene Chemical group C1=CC=C2[C]C=CC2=C1 VRBHURBJIHILRI-UHFFFAOYSA-N 0.000 description 14
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 10
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 10
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 10
- 230000003197 catalytic effect Effects 0.000 description 9
- 238000005686 cross metathesis reaction Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 7
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 7
- 238000000607 proton-decoupled 31P nuclear magnetic resonance spectroscopy Methods 0.000 description 7
- 230000035484 reaction time Effects 0.000 description 7
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 5
- 238000004679 31P NMR spectroscopy Methods 0.000 description 5
- OKXHMBXWZHCSMR-UHFFFAOYSA-N 4-methyl-n,n-bis(prop-2-enyl)benzenesulfonamide Chemical compound CC1=CC=C(S(=O)(=O)N(CC=C)CC=C)C=C1 OKXHMBXWZHCSMR-UHFFFAOYSA-N 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 5
- KFYPHCIBZTZQBW-UHFFFAOYSA-N C=CC1=CCOC1(C)C1=CC=CC=C1 Chemical compound C=CC1=CCOC1(C)C1=CC=CC=C1 KFYPHCIBZTZQBW-UHFFFAOYSA-N 0.000 description 5
- LGJWCOHFOKIUHE-UHFFFAOYSA-N C=CCC(CC)(CC(=C)C)C(=O)OCC.O=C=O Chemical compound C=CCC(CC)(CC(=C)C)C(=O)OCC.O=C=O LGJWCOHFOKIUHE-UHFFFAOYSA-N 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 5
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 5
- GWOPOSOALALBRZ-UHFFFAOYSA-N C#CC(C)(OCC=C)C1=CC=CC=C1 Chemical compound C#CC(C)(OCC=C)C1=CC=CC=C1 GWOPOSOALALBRZ-UHFFFAOYSA-N 0.000 description 4
- YVXBNVHZJIXFNM-UHFFFAOYSA-N CCOC(=O)C1(CC)CC=C(C)C1.O=C=O Chemical compound CCOC(=O)C1(CC)CC=C(C)C1.O=C=O YVXBNVHZJIXFNM-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 150000001993 dienes Chemical class 0.000 description 4
- VURFVHCLMJOLKN-UHFFFAOYSA-N diphosphane Chemical compound PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- SJHCUXCOGGKFAI-UHFFFAOYSA-N tripropan-2-yl phosphite Chemical compound CC(C)OP(OC(C)C)OC(C)C SJHCUXCOGGKFAI-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 3
- LSMWOQFDLBIYPM-UHFFFAOYSA-N 1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydro-2h-imidazol-1-ium-2-ide Chemical compound CC1=CC(C)=CC(C)=C1N1[C-]=[N+](C=2C(=CC(C)=CC=2C)C)CC1 LSMWOQFDLBIYPM-UHFFFAOYSA-N 0.000 description 3
- NGYCXWSVZAFSHH-UHFFFAOYSA-N C=C(C)CCN(CC(=C)C)S(=O)(=O)C1=CC=C(C)C=C1 Chemical compound C=C(C)CCN(CC(=C)C)S(=O)(=O)C1=CC=C(C)C=C1 NGYCXWSVZAFSHH-UHFFFAOYSA-N 0.000 description 3
- PKHNSZKEBSLONY-UHFFFAOYSA-N C=C(C)CN(CC(=C)C)S(=O)(=O)C1=CC=C(C)C=C1 Chemical compound C=C(C)CN(CC(=C)C)S(=O)(=O)C1=CC=C(C)C=C1 PKHNSZKEBSLONY-UHFFFAOYSA-N 0.000 description 3
- XXZPAAPAXWGGGH-UHFFFAOYSA-N C=CCC(CC)(CC=C)C(=O)OCC.O=C=O Chemical compound C=CCC(CC)(CC=C)C(=O)OCC.O=C=O XXZPAAPAXWGGGH-UHFFFAOYSA-N 0.000 description 3
- UGBLDJOGQRDQTJ-UHFFFAOYSA-N C=CCCC(CC)(CC=C)C(=O)OCC.O=C=O Chemical compound C=CCCC(CC)(CC=C)C(=O)OCC.O=C=O UGBLDJOGQRDQTJ-UHFFFAOYSA-N 0.000 description 3
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N C=CCCCCC Chemical compound C=CCCCCC ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 3
- GFHSWQCNAFAFMO-UHFFFAOYSA-N C=CCCN(CC=C)S(=O)(=O)C1=CC=C(C)C=C1 Chemical compound C=CCCN(CC=C)S(=O)(=O)C1=CC=C(C)C=C1 GFHSWQCNAFAFMO-UHFFFAOYSA-N 0.000 description 3
- JBLBGQZIZNSGGI-UHFFFAOYSA-N CC(C)C1=CC=CC(C(C)C)=C1N1[C]N(C2=C(C(C)C)C=CC=C2C(C)C)C=C1.CC(C)C1=CC=CC(C(C)C)=C1N1[C]N(C2=C(C(C)C)C=CC=C2C(C)C)CC1.CC1=CC(C)=C(I)C(C)=C1.CC1=CC(C)=C(N2[C]N(C3=C(C)C=C(C)C=C3C)C=C2)C(C)=C1.CC1=CC(C)=C(N2[C]N(C3=C(C)C=C(C)C=C3C)CC2)C(C)=C1.CC1=CC(C)=C(SI)C(C)=C1.CCCI.CCCSI Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N1[C]N(C2=C(C(C)C)C=CC=C2C(C)C)C=C1.CC(C)C1=CC=CC(C(C)C)=C1N1[C]N(C2=C(C(C)C)C=CC=C2C(C)C)CC1.CC1=CC(C)=C(I)C(C)=C1.CC1=CC(C)=C(N2[C]N(C3=C(C)C=C(C)C=C3C)C=C2)C(C)=C1.CC1=CC(C)=C(N2[C]N(C3=C(C)C=C(C)C=C3C)CC2)C(C)=C1.CC1=CC(C)=C(SI)C(C)=C1.CCCI.CCCSI JBLBGQZIZNSGGI-UHFFFAOYSA-N 0.000 description 3
- UNYMIBRUQCUASP-UHFFFAOYSA-N CC1=CC=C(S(=O)(=O)N2CC=CC2)C=C1 Chemical compound CC1=CC=C(S(=O)(=O)N2CC=CC2)C=C1 UNYMIBRUQCUASP-UHFFFAOYSA-N 0.000 description 3
- CJBQSBZJDJHMLF-BQYQJAHWSA-N CCCCC/C=C/C(=O)OC Chemical compound CCCCC/C=C/C(=O)OC CJBQSBZJDJHMLF-BQYQJAHWSA-N 0.000 description 3
- 238000005865 alkene metathesis reaction Methods 0.000 description 3
- 125000001118 alkylidene group Chemical group 0.000 description 3
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 3
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 238000002424 x-ray crystallography Methods 0.000 description 3
- XZDYFCGKKKSOEY-UHFFFAOYSA-N 1,3-bis[2,6-di(propan-2-yl)phenyl]-4,5-dihydro-2h-imidazol-1-ium-2-ide Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N1CCN(C=2C(=CC=CC=2C(C)C)C(C)C)[C]1 XZDYFCGKKKSOEY-UHFFFAOYSA-N 0.000 description 2
- KTZVZZJJVJQZHV-UHFFFAOYSA-N 1-chloro-4-ethenylbenzene Chemical compound ClC1=CC=C(C=C)C=C1 KTZVZZJJVJQZHV-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- UQRONKZLYKUEMO-UHFFFAOYSA-N 4-methyl-1-(2,4,6-trimethylphenyl)pent-4-en-2-one Chemical group CC(=C)CC(=O)Cc1c(C)cc(C)cc1C UQRONKZLYKUEMO-UHFFFAOYSA-N 0.000 description 2
- SQMCYQSCMCMEIL-UHFFFAOYSA-N 4-methyl-n-prop-2-enylbenzenesulfonamide Chemical compound CC1=CC=C(S(=O)(=O)NCC=C)C=C1 SQMCYQSCMCMEIL-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VBAGSFPQGOBWAX-UHFFFAOYSA-N C=C(C)CC(CC)(CC(=C)C)C(=O)OCC.O=C=O Chemical compound C=C(C)CC(CC)(CC(=C)C)C(=O)OCC.O=C=O VBAGSFPQGOBWAX-UHFFFAOYSA-N 0.000 description 2
- QRXALYNOSRIBCJ-UHFFFAOYSA-N C=CC(OCC(=C)C)C1=CC=CC=C1 Chemical compound C=CC(OCC(=C)C)C1=CC=CC=C1 QRXALYNOSRIBCJ-UHFFFAOYSA-N 0.000 description 2
- VQJJJPBNIXFEFB-UHFFFAOYSA-N C=CCOC(CC=C)C1=CC=CC=C1 Chemical compound C=CCOC(CC=C)C1=CC=CC=C1 VQJJJPBNIXFEFB-UHFFFAOYSA-N 0.000 description 2
- YDGORPUKQGPRJC-UHFFFAOYSA-N CC1=CC(C)=C(N2[C]N(C3=C(C)C=C(C)C=C3C)CC2)C(C)=C1.CC1=CC(C)=C(SI)C(C)=C1 Chemical compound CC1=CC(C)=C(N2[C]N(C3=C(C)C=C(C)C=C3C)CC2)C(C)=C1.CC1=CC(C)=C(SI)C(C)=C1 YDGORPUKQGPRJC-UHFFFAOYSA-N 0.000 description 2
- SAJIORDGUDQIPQ-UHFFFAOYSA-N CC1=CC=C(S(=O)(=O)N2CC(C)=C(C)C2)C=C1 Chemical compound CC1=CC=C(S(=O)(=O)N2CC(C)=C(C)C2)C=C1 SAJIORDGUDQIPQ-UHFFFAOYSA-N 0.000 description 2
- ZMTDDBMFBZAZMT-UHFFFAOYSA-N CC1=CC=C(S(=O)(=O)N2CC=CCC2)C=C1 Chemical compound CC1=CC=C(S(=O)(=O)N2CC=CCC2)C=C1 ZMTDDBMFBZAZMT-UHFFFAOYSA-N 0.000 description 2
- OGTCXECJTCTTNS-UHFFFAOYSA-N CC1=CC=C(S(=O)(=O)N2CCC(C)=C(C)C2)C=C1 Chemical compound CC1=CC=C(S(=O)(=O)N2CCC(C)=C(C)C2)C=C1 OGTCXECJTCTTNS-UHFFFAOYSA-N 0.000 description 2
- QKSUHIFSISIYTD-UHFFFAOYSA-N CCOC(=O)C1(CC)CC(C)=C(C)C1.O=C=O Chemical compound CCOC(=O)C1(CC)CC(C)=C(C)C1.O=C=O QKSUHIFSISIYTD-UHFFFAOYSA-N 0.000 description 2
- VLOGNRKVAQWYOV-UHFFFAOYSA-N CCOC(=O)C1(CC)CC=CC1.O=C=O Chemical compound CCOC(=O)C1(CC)CC=CC1.O=C=O VLOGNRKVAQWYOV-UHFFFAOYSA-N 0.000 description 2
- GNVUSXORMZJKMG-UHFFFAOYSA-N CCOC(=O)C1(CC)CC=CCC1.O=C=O Chemical compound CCOC(=O)C1(CC)CC=CCC1.O=C=O GNVUSXORMZJKMG-UHFFFAOYSA-N 0.000 description 2
- AKPCVVSJIGAQKR-WEVVVXLNSA-N COC(=O)/C=C/CCOC(=O)C1=CC=CC=C1 Chemical compound COC(=O)/C=C/CCOC(=O)C1=CC=CC=C1 AKPCVVSJIGAQKR-WEVVVXLNSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- KUGDOHYKOXCGOR-UHFFFAOYSA-N O=C(C1=CC=CC=C1)N1CC=CC1 Chemical compound O=C(C1=CC=CC=C1)N1CC=CC1 KUGDOHYKOXCGOR-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000001805 chlorine compounds Chemical group 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- DHCWLIOIJZJFJE-UHFFFAOYSA-L dichlororuthenium Chemical compound Cl[Ru]Cl DHCWLIOIJZJFJE-UHFFFAOYSA-L 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 2
- 125000004437 phosphorous atom Chemical group 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000012041 precatalyst Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000005872 self-metathesis reaction Methods 0.000 description 2
- 229910001544 silver hexafluoroantimonate(V) Inorganic materials 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000007725 thermal activation Methods 0.000 description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 2
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 2
- RRKODOZNUZCUBN-CCAGOZQPSA-N (1z,3z)-cycloocta-1,3-diene Chemical compound C1CC\C=C/C=C\C1 RRKODOZNUZCUBN-CCAGOZQPSA-N 0.000 description 1
- HCMJWOGOISXSDL-UHFFFAOYSA-N (2-isothiocyanato-1-phenylethyl)benzene Chemical compound C=1C=CC=CC=1C(CN=C=S)C1=CC=CC=C1 HCMJWOGOISXSDL-UHFFFAOYSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 description 1
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 1
- 125000003363 1,3,5-triazinyl group Chemical group N1=C(N=CN=C1)* 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- HKCYFNNGQFYBFB-UHFFFAOYSA-N C#CC(C)(OCC(=C)C)C1=CC=CC=C1 Chemical compound C#CC(C)(OCC(=C)C)C1=CC=CC=C1 HKCYFNNGQFYBFB-UHFFFAOYSA-N 0.000 description 1
- AEBLBILZFUKEPL-UHFFFAOYSA-N C#CC(OCC=C)(C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C#CC(OCC=C)(C1=CC=CC=C1)C1=CC=CC=C1 AEBLBILZFUKEPL-UHFFFAOYSA-N 0.000 description 1
- MEAGLNLRQYMYLK-UHFFFAOYSA-N C#CCN(CC=C(C)C)S(=O)(=O)C1=CC=C(C)C=C1 Chemical compound C#CCN(CC=C(C)C)S(=O)(=O)C1=CC=C(C)C=C1 MEAGLNLRQYMYLK-UHFFFAOYSA-N 0.000 description 1
- QITLNHICIUWDTD-UHFFFAOYSA-N C#CCN(CC=C)S(=O)(=O)C1=CC=C(C)C=C1 Chemical compound C#CCN(CC=C)S(=O)(=O)C1=CC=C(C)C=C1 QITLNHICIUWDTD-UHFFFAOYSA-N 0.000 description 1
- FNKYYJHLNVEJHN-UHFFFAOYSA-A C#N.CC#N.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](C)(Cl)=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)O(C(C)C)P(OC(C)C)OC(C)C)C(C)=C1.F[Sb](F)(F)(F)F.F[Sb](F)(F)(F)F.[F-].[F-] Chemical compound C#N.CC#N.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](C)(Cl)=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)O(C(C)C)P(OC(C)C)OC(C)C)C(C)=C1.F[Sb](F)(F)(F)F.F[Sb](F)(F)(F)F.[F-].[F-] FNKYYJHLNVEJHN-UHFFFAOYSA-A 0.000 description 1
- IXVNNWSTHRNZDO-UHFFFAOYSA-K C.C.C.CC(C)OP(OC(C)C)O(C(C)C)[Ru](Cl)(Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)[PH](OC(C)C)(OC(C)C)OC(C)C.C[Ru](Cl)(Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)[PH](C1CCCCC1)(C1CCCCC1)C1CCCCC1 Chemical compound C.C.C.CC(C)OP(OC(C)C)O(C(C)C)[Ru](Cl)(Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)[PH](OC(C)C)(OC(C)C)OC(C)C.C[Ru](Cl)(Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)[PH](C1CCCCC1)(C1CCCCC1)C1CCCCC1 IXVNNWSTHRNZDO-UHFFFAOYSA-K 0.000 description 1
- SOQBTYLDDYYEKR-UHFFFAOYSA-J C.C.CC(C)OP(OC(C)C)OC(C)C.CC(C)O[PH](OC(C)C)(OC(C)C)[Ru](C)(Cl)(Cl)=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2.C[Ru](Cl)(Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)[PH](C1CCCCC1)(C1CCCCC1)C1CCCCC1 Chemical compound C.C.CC(C)OP(OC(C)C)OC(C)C.CC(C)O[PH](OC(C)C)(OC(C)C)[Ru](C)(Cl)(Cl)=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2.C[Ru](Cl)(Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)[PH](C1CCCCC1)(C1CCCCC1)C1CCCCC1 SOQBTYLDDYYEKR-UHFFFAOYSA-J 0.000 description 1
- RCMDXHBHUDIVFP-UHFFFAOYSA-J C.CC(C)OP(OC(C)C)OC(C)C.CC1=CC(C)=C([SH](I)[Ru](Cl)(Cl)(=CC2=CC=CC=C2OC(C)C)[PH](OC(C)C)(OC(C)C)OC(C)C)C(C)=C1.CC1=CC(C)=C([SH](I)[Ru]2(Cl)(Cl)=CC3=C(C=CC=C3)O2C(C)C)C(C)=C1.II Chemical compound C.CC(C)OP(OC(C)C)OC(C)C.CC1=CC(C)=C([SH](I)[Ru](Cl)(Cl)(=CC2=CC=CC=C2OC(C)C)[PH](OC(C)C)(OC(C)C)OC(C)C)C(C)=C1.CC1=CC(C)=C([SH](I)[Ru]2(Cl)(Cl)=CC3=C(C=CC=C3)O2C(C)C)C(C)=C1.II RCMDXHBHUDIVFP-UHFFFAOYSA-J 0.000 description 1
- LLYGUPBPHYVFNG-UHFFFAOYSA-J C.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](C)(Cl)(Cl)=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](C)(Cl)(Cl)=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)C(C)=C1.CC1=CC=C(OP)C=C1 Chemical compound C.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](C)(Cl)(Cl)=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](C)(Cl)(Cl)=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)C(C)=C1.CC1=CC=C(OP)C=C1 LLYGUPBPHYVFNG-UHFFFAOYSA-J 0.000 description 1
- LZZFRVVSOPBGCF-UHFFFAOYSA-J C.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=C2/C=C(\C3=CC=CC=C3)C3=C2C=CC=C3)[PH](C2CCCCC2)(C2CCCCC2)C2CCCCC2)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=CC2=CC=CC=C2)[PH](C2CCCCC2)(C2CCCCC2)C2CCCCC2)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru]2(Cl)(Cl)=CC3=CC=CC=C3O2C(C)C)C(C)=C1 Chemical compound C.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=C2/C=C(\C3=CC=CC=C3)C3=C2C=CC=C3)[PH](C2CCCCC2)(C2CCCCC2)C2CCCCC2)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=CC2=CC=CC=C2)[PH](C2CCCCC2)(C2CCCCC2)C2CCCCC2)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru]2(Cl)(Cl)=CC3=CC=CC=C3O2C(C)C)C(C)=C1 LZZFRVVSOPBGCF-UHFFFAOYSA-J 0.000 description 1
- YNDPEFKHBGCWDR-UHFFFAOYSA-N C1=CC=C(C2CC=CCO2)C=C1 Chemical compound C1=CC=C(C2CC=CCO2)C=C1 YNDPEFKHBGCWDR-UHFFFAOYSA-N 0.000 description 1
- QBIBANDTMLADIJ-UHFFFAOYSA-N C1=CC=C2C(=[Ru])C=CC2=C1 Chemical class C1=CC=C2C(=[Ru])C=CC2=C1 QBIBANDTMLADIJ-UHFFFAOYSA-N 0.000 description 1
- KYNSBQPICQTCGU-UHFFFAOYSA-N C1=CC=C2OCC=CC2=C1 Chemical compound C1=CC=C2OCC=CC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 1
- RJCHLKZWCLIACQ-UHFFFAOYSA-N C1=CC=C2OCC=CCC2=C1 Chemical compound C1=CC=C2OCC=CCC2=C1 RJCHLKZWCLIACQ-UHFFFAOYSA-N 0.000 description 1
- ZXVVBHVQWWXUJI-UHFFFAOYSA-N C=C(C)CC(CC(=C)C)(C(=O)OCC)C(=O)OCC Chemical compound C=C(C)CC(CC(=C)C)(C(=O)OCC)C(=O)OCC ZXVVBHVQWWXUJI-UHFFFAOYSA-N 0.000 description 1
- CKKGIBPJAWDKAW-UHFFFAOYSA-N C=C(C)CN(CC(=C)C)S(=O)(=O)C1=CC=C(C)C=C1.CC1=CC=C(S(=O)(=O)N2CC(C)=C(C)C2)C=C1 Chemical compound C=C(C)CN(CC(=C)C)S(=O)(=O)C1=CC=C(C)C=C1.CC1=CC=C(S(=O)(=O)N2CC(C)=C(C)C2)C=C1 CKKGIBPJAWDKAW-UHFFFAOYSA-N 0.000 description 1
- ZYHMNFDBORXIPD-UHFFFAOYSA-N C=CC1=C(C)COC1(C)C1=CC=CC=C1 Chemical compound C=CC1=C(C)COC1(C)C1=CC=CC=C1 ZYHMNFDBORXIPD-UHFFFAOYSA-N 0.000 description 1
- INFDSAMNRVVYPN-UHFFFAOYSA-N C=CC1=CCN(S(=O)(=O)C2=CC=C(C)C=C2)C1 Chemical compound C=CC1=CCN(S(=O)(=O)C2=CC=C(C)C=C2)C1 INFDSAMNRVVYPN-UHFFFAOYSA-N 0.000 description 1
- CZFFQPOZMMLBRV-UHFFFAOYSA-N C=CC1=CCOC1(C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C=CC1=CCOC1(C1=CC=CC=C1)C1=CC=CC=C1 CZFFQPOZMMLBRV-UHFFFAOYSA-N 0.000 description 1
- BEYRARVOHDHKTG-UHFFFAOYSA-N C=CCC1=CC(C)=C(O)C=C1 Chemical compound C=CCC1=CC(C)=C(O)C=C1 BEYRARVOHDHKTG-UHFFFAOYSA-N 0.000 description 1
- FNMHKQVEFZLMQD-UHFFFAOYSA-N C=CCCCC(=O)C1=CC=CC=C1 Chemical compound C=CCCCC(=O)C1=CC=CC=C1 FNMHKQVEFZLMQD-UHFFFAOYSA-N 0.000 description 1
- SJAFDVGTTHZAHF-UHFFFAOYSA-N C=CCCCC(CC)(CC=C)C(=O)OCC.O=C=O Chemical compound C=CCCCC(CC)(CC=C)C(=O)OCC.O=C=O SJAFDVGTTHZAHF-UHFFFAOYSA-N 0.000 description 1
- IGSOUDJENGOUBC-UHFFFAOYSA-N C=CCCCN(CC=C)S(=O)(=O)C1=CC=C(C)C=C1 Chemical compound C=CCCCN(CC=C)S(=O)(=O)C1=CC=C(C)C=C1 IGSOUDJENGOUBC-UHFFFAOYSA-N 0.000 description 1
- MFUGAJWSACDNNH-UHFFFAOYSA-N C=CCCCOC(=O)C1=CC=CC=C1 Chemical compound C=CCCCOC(=O)C1=CC=CC=C1 MFUGAJWSACDNNH-UHFFFAOYSA-N 0.000 description 1
- HCAQKYMCZZDLGU-UHFFFAOYSA-N C=CCCOC(=O)C1=CC=CC=C1 Chemical compound C=CCCOC(=O)C1=CC=CC=C1 HCAQKYMCZZDLGU-UHFFFAOYSA-N 0.000 description 1
- WJUWKNWIOVQEEI-UHFFFAOYSA-N C=CCN(CC=C)C(=O)C1=CC=CC=C1 Chemical compound C=CCN(CC=C)C(=O)C1=CC=CC=C1 WJUWKNWIOVQEEI-UHFFFAOYSA-N 0.000 description 1
- BHKMFRWVILQIFL-UHFFFAOYSA-N C=CCOC1=CC=CC=C1C=C Chemical compound C=CCOC1=CC=CC=C1C=C BHKMFRWVILQIFL-UHFFFAOYSA-N 0.000 description 1
- LRGCQJJYMUCWGH-UHFFFAOYSA-N C=CCOC1=CC=CC=C1CC=C Chemical compound C=CCOC1=CC=CC=C1CC=C LRGCQJJYMUCWGH-UHFFFAOYSA-N 0.000 description 1
- AOXQIYAXTFTNQV-UHFFFAOYSA-N CC(C)=CC1=CCN(S(=O)(=O)C2=CC=C(C)C=C2)C1 Chemical compound CC(C)=CC1=CCN(S(=O)(=O)C2=CC=C(C)C=C2)C1 AOXQIYAXTFTNQV-UHFFFAOYSA-N 0.000 description 1
- ZIASSMNQPIRVFF-UHFFFAOYSA-J CC(C)C1=CC=CC(C(C)C)=C1N1CCN(C2=C(C(C)C)C=CC=C2C(C)C)C1[Ru](C)(Cl)(Cl)=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2.CC(C)OP(OC(C)C)OC(C)C.CC(C)O[PH](OC(C)C)(OC(C)C)[Ru](Cl)(Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)C1N(C2=C(C(C)C)C=CC=C2C(C)C)CCN1C1=C(C(C)C)C=CC=C1C(C)C Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N1CCN(C2=C(C(C)C)C=CC=C2C(C)C)C1[Ru](C)(Cl)(Cl)=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2.CC(C)OP(OC(C)C)OC(C)C.CC(C)O[PH](OC(C)C)(OC(C)C)[Ru](Cl)(Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)C1N(C2=C(C(C)C)C=CC=C2C(C)C)CCN1C1=C(C(C)C)C=CC=C1C(C)C ZIASSMNQPIRVFF-UHFFFAOYSA-J 0.000 description 1
- CTMKXOQMRRGIRI-UHFFFAOYSA-N CC(C)C1=CC=CC(C(C)C)=C1N1[C]N(C2=C(C(C)C)C=CC=C2C(C)C)CC1.CC1=CC(C)=C(N2[C]N(C3=C(C)C=C(C)C=C3C)CC2)C(C)=C1.CC1=CC(C)=C(SI)C(C)=C1.CCCSI Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N1[C]N(C2=C(C(C)C)C=CC=C2C(C)C)CC1.CC1=CC(C)=C(N2[C]N(C3=C(C)C=C(C)C=C3C)CC2)C(C)=C1.CC1=CC(C)=C(SI)C(C)=C1.CCCSI CTMKXOQMRRGIRI-UHFFFAOYSA-N 0.000 description 1
- BGDWAKVNGSIQLH-SFVWDYPZSA-N CC(C)Oc1c(C=[N](C)([C@H]2C)(C2[N+]([O-])=O)(N)=C)cccc1 Chemical compound CC(C)Oc1c(C=[N](C)([C@H]2C)(C2[N+]([O-])=O)(N)=C)cccc1 BGDWAKVNGSIQLH-SFVWDYPZSA-N 0.000 description 1
- WGGJTPQHVFOGPN-PLNGDYQASA-N CC/C=C\COC(C)=O Chemical compound CC/C=C\COC(C)=O WGGJTPQHVFOGPN-PLNGDYQASA-N 0.000 description 1
- BKLPKQLMGDXBTE-UHFFFAOYSA-K CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)O(C(C)C)P(OC(C)C)OC(C)C)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)[PH](OC(C)C)(OC(C)C)OC(C)C)C(C)=C1 Chemical compound CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)O(C(C)C)P(OC(C)C)OC(C)C)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)[PH](OC(C)C)(OC(C)C)OC(C)C)C(C)=C1 BKLPKQLMGDXBTE-UHFFFAOYSA-K 0.000 description 1
- PELVRVQVVRAGJI-UHFFFAOYSA-A CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)O(C(C)C)P(OC(C)C)OC(C)C)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)[PH](OC(C)C)(OC(C)C)OC(C)C)C(C)=C1.F[Sb](F)(F)(F)(F)(F)[Ag].F[Sb](F)(F)(F)F.[F-] Chemical compound CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)O(C(C)C)P(OC(C)C)OC(C)C)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)[PH](OC(C)C)(OC(C)C)OC(C)C)C(C)=C1.F[Sb](F)(F)(F)(F)(F)[Ag].F[Sb](F)(F)(F)F.[F-] PELVRVQVVRAGJI-UHFFFAOYSA-A 0.000 description 1
- VCRJUUKRDSDGPH-UHFFFAOYSA-H CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)[PH](C2CCCCC2)(C2CCCCC2)C2CCCCC2)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=CC2=CC=CC=C2)[PH](C2CCCCC2)(C2CCCCC2)C2CCCCC2)C(C)=C1.Cl[Ru](Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)([PH](C1CCCCC1)(C1CCCCC1)C1CCCCC1)[PH](C1CCCCC1)(C1CCCCC1)C1CCCCC1 Chemical compound CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=C2C=C(C3=CC=CC=C3)C3=C2C=CC=C3)[PH](C2CCCCC2)(C2CCCCC2)C2CCCCC2)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)(=CC2=CC=CC=C2)[PH](C2CCCCC2)(C2CCCCC2)C2CCCCC2)C(C)=C1.Cl[Ru](Cl)(=C1C=C(C2=CC=CC=C2)C2=C1C=CC=C2)([PH](C1CCCCC1)(C1CCCCC1)C1CCCCC1)[PH](C1CCCCC1)(C1CCCCC1)C1CCCCC1 VCRJUUKRDSDGPH-UHFFFAOYSA-H 0.000 description 1
- JRZILHLONJRPMN-UHFFFAOYSA-H CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)=CCCC2=NC=CC=C2)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru]2(Cl)(Cl)=Cc3ccccc3C=O2)C(C)=C1.[H]C1([H])C[Ru](Cl)(Cl)(=CC=C(C)C)P1C Chemical compound CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru](Cl)(Cl)=CCCC2=NC=CC=C2)C(C)=C1.CC1=CC(C)=C(N2CCN(C3=C(C)C=C(C)C=C3C)C2[Ru]2(Cl)(Cl)=Cc3ccccc3C=O2)C(C)=C1.[H]C1([H])C[Ru](Cl)(Cl)(=CC=C(C)C)P1C JRZILHLONJRPMN-UHFFFAOYSA-H 0.000 description 1
- SPYQTLKJWWYXLA-UHFFFAOYSA-L CC1=CC(C)=C(N2CCN(CCO)C2[Ru](C)(Cl)(Cl)=CC2=CC=CC=C2)C(C)=C1 Chemical compound CC1=CC(C)=C(N2CCN(CCO)C2[Ru](C)(Cl)(Cl)=CC2=CC=CC=C2)C(C)=C1 SPYQTLKJWWYXLA-UHFFFAOYSA-L 0.000 description 1
- BHIRLSBQCZZEOO-UHFFFAOYSA-N CC1=CC(C2=CC=CC=C2)OC1 Chemical compound CC1=CC(C2=CC=CC=C2)OC1 BHIRLSBQCZZEOO-UHFFFAOYSA-N 0.000 description 1
- PVCPYGAWYPKUGU-UHFFFAOYSA-N CC1=CC=C(S(=O)(=O)N2CC=CCCC2)C=C1 Chemical compound CC1=CC=C(S(=O)(=O)N2CC=CCCC2)C=C1 PVCPYGAWYPKUGU-UHFFFAOYSA-N 0.000 description 1
- XKGLSKVNOSHTAD-UHFFFAOYSA-N CCCCC(c1ccccc1)=O Chemical compound CCCCC(c1ccccc1)=O XKGLSKVNOSHTAD-UHFFFAOYSA-N 0.000 description 1
- AAVNKIVCLRAVOX-BQYQJAHWSA-N CCCCC/C=C/CNS(=O)(=O)C1=CC=C(C)C=C1 Chemical compound CCCCC/C=C/CNS(=O)(=O)C1=CC=C(C)C=C1 AAVNKIVCLRAVOX-BQYQJAHWSA-N 0.000 description 1
- MBRLTLPMVMFRTJ-BQYQJAHWSA-N CCCCC/C=C/COC(C)=O Chemical compound CCCCC/C=C/COC(C)=O MBRLTLPMVMFRTJ-BQYQJAHWSA-N 0.000 description 1
- ZJFKTBQIXQBYBZ-UHFFFAOYSA-N CCOC(=O)C1(CC)CC=CCCC1.O=C=O Chemical compound CCOC(=O)C1(CC)CC=CCCC1.O=C=O ZJFKTBQIXQBYBZ-UHFFFAOYSA-N 0.000 description 1
- QTODRVZOLZZSQD-UHFFFAOYSA-L CC[PH](=O)(CC)(CC)[Ru]1(Cl)(C2N(C3=C(C)C=C(C)C=C3C)CCN2C2=C(C)C=C(C)C=C2C)=Cc2cc(C)ccc2C(OC(C)C)=O1.[Cl-] Chemical compound CC[PH](=O)(CC)(CC)[Ru]1(Cl)(C2N(C3=C(C)C=C(C)C=C3C)CCN2C2=C(C)C=C(C)C=C2C)=Cc2cc(C)ccc2C(OC(C)C)=O1.[Cl-] QTODRVZOLZZSQD-UHFFFAOYSA-L 0.000 description 1
- IIBXQGYKZKOORG-QPJJXVBHSA-N COC(=O)/C=C/C1=CC=C(Cl)C=C1 Chemical compound COC(=O)/C=C/C1=CC=C(Cl)C=C1 IIBXQGYKZKOORG-QPJJXVBHSA-N 0.000 description 1
- UCVCATRBIZCAOA-UXBLZVDNSA-N COC(=O)/C=C/CCCOC(=O)C1=CC=CC=C1 Chemical compound COC(=O)/C=C/CCCOC(=O)C1=CC=CC=C1 UCVCATRBIZCAOA-UXBLZVDNSA-N 0.000 description 1
- VIICRACEUGGFEH-UHFFFAOYSA-N COC(=O)C=CCCCC(=O)C1=CC=CC=C1 Chemical compound COC(=O)C=CCCCC(=O)C1=CC=CC=C1 VIICRACEUGGFEH-UHFFFAOYSA-N 0.000 description 1
- RCJDUUKNIXWZMG-UHFFFAOYSA-N COC1=CC=C(C=C1)P(O)(O)O Chemical compound COC1=CC=C(C=C1)P(O)(O)O RCJDUUKNIXWZMG-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- IQOVEHDICZIXNZ-UHFFFAOYSA-N ClC1=CC=C(C=C1)P(O)(O)O Chemical compound ClC1=CC=C(C=C1)P(O)(O)O IQOVEHDICZIXNZ-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 238000012565 NMR experiment Methods 0.000 description 1
- HXGYIZDTERCABK-UHFFFAOYSA-N OP(C1=CC=C(C(F)(F)F)C=C1)(O)O Chemical compound OP(C1=CC=C(C(F)(F)F)C=C1)(O)O HXGYIZDTERCABK-UHFFFAOYSA-N 0.000 description 1
- INZTYASSBPFBSA-UHFFFAOYSA-N OP(O)(O)C1=CC=C(C=C1)[N+]([O-])=O Chemical compound OP(O)(O)C1=CC=C(C=C1)[N+]([O-])=O INZTYASSBPFBSA-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- NOEKTNQTHRDFCF-UHFFFAOYSA-N P([O-])([O-])[O-].[Ru+3] Chemical class P([O-])([O-])[O-].[Ru+3] NOEKTNQTHRDFCF-UHFFFAOYSA-N 0.000 description 1
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- IGRZCRSYIUUAJU-UHFFFAOYSA-N [C-]#[N+]C(C#N)(CC(=C)C)CC(=C)C Chemical compound [C-]#[N+]C(C#N)(CC(=C)C)CC(=C)C IGRZCRSYIUUAJU-UHFFFAOYSA-N 0.000 description 1
- WQGKZUBTEFGLBU-UHFFFAOYSA-N [C-]#[N+]C(C#N)(CC=C)CC=C Chemical compound [C-]#[N+]C(C#N)(CC=C)CC=C WQGKZUBTEFGLBU-UHFFFAOYSA-N 0.000 description 1
- XHOIWCUMMBCVSX-UHFFFAOYSA-N [C-]#[N+]C1(C#N)CC(C)=C(C)C1 Chemical compound [C-]#[N+]C1(C#N)CC(C)=C(C)C1 XHOIWCUMMBCVSX-UHFFFAOYSA-N 0.000 description 1
- DXPIVJVDHMPXDZ-UHFFFAOYSA-N [C-]#[N+]C1(C#N)CC=CC1 Chemical compound [C-]#[N+]C1(C#N)CC=CC1 DXPIVJVDHMPXDZ-UHFFFAOYSA-N 0.000 description 1
- WVSGRYFMJUVQTG-UHFFFAOYSA-N [C]=C1C=Cc2ccccc12 Chemical group [C]=C1C=Cc2ccccc12 WVSGRYFMJUVQTG-UHFFFAOYSA-N 0.000 description 1
- OGOHCHOOQZSYIK-NSCUHMNNSA-N [H]C(=O)/C=C/CC1=CC(C)=C(O)C=C1 Chemical compound [H]C(=O)/C=C/CC1=CC(C)=C(O)C=C1 OGOHCHOOQZSYIK-NSCUHMNNSA-N 0.000 description 1
- LVBXEMGDVWVTGY-VOTSOKGWSA-N [H]C(=O)/C=C/CCCCC Chemical compound [H]C(=O)/C=C/CCCCC LVBXEMGDVWVTGY-VOTSOKGWSA-N 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000012018 catalyst precursor Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910001914 chlorine tetroxide Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical compound [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- SOCTUWSJJQCPFX-UHFFFAOYSA-N dichromate(2-) Chemical compound [O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O SOCTUWSJJQCPFX-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940094933 n-dodecane Drugs 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-FIBGUPNXSA-N nitromethane-d3 Chemical compound [2H]C([2H])([2H])[N+]([O-])=O LYGJENNIWJXYER-FIBGUPNXSA-N 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- ZOGYOOUMDVKYLM-UHFFFAOYSA-N phosphane phosphorous acid Chemical compound P.OP(O)O ZOGYOOUMDVKYLM-UHFFFAOYSA-N 0.000 description 1
- GTBPUYSGSDIIMM-UHFFFAOYSA-N phosphane;ruthenium Chemical class P.[Ru] GTBPUYSGSDIIMM-UHFFFAOYSA-N 0.000 description 1
- 125000005538 phosphinite group Chemical group 0.000 description 1
- XRBCRPZXSCBRTK-UHFFFAOYSA-N phosphonous acid Chemical compound OPO XRBCRPZXSCBRTK-UHFFFAOYSA-N 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000010107 reaction injection moulding Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CRDYSYOERSZTHZ-UHFFFAOYSA-M selenocyanate Chemical compound [Se-]C#N CRDYSYOERSZTHZ-UHFFFAOYSA-M 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 125000003441 thioacyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- YXFVVABEGXRONW-JGUCLWPXSA-N toluene-d8 Chemical compound [2H]C1=C([2H])C([2H])=C(C([2H])([2H])[2H])C([2H])=C1[2H] YXFVVABEGXRONW-JGUCLWPXSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/317—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
- C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
- C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
- C07C13/44—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with a bicyclo ring system containing eight carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C6/00—Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions
- C07C6/02—Metathesis reactions at an unsaturated carbon-to-carbon bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/75—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of acids with a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C07F7/1852—
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G61/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G61/02—Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes
- C08G61/04—Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes only aliphatic carbon atoms
- C08G61/06—Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes only aliphatic carbon atoms prepared by ring-opening of carbocyclic compounds
- C08G61/08—Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes only aliphatic carbon atoms prepared by ring-opening of carbocyclic compounds of carbocyclic compounds containing one or more carbon-to-carbon double bonds in the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- C07C2531/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- C07C2531/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- C07C2531/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- C07C2531/22—Organic complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- C07C2531/26—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups C07C2531/02 - C07C2531/24
- C07C2531/28—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups C07C2531/02 - C07C2531/24 of the platinum group metals, iron group metals or copper
- C07C2531/30—Halides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/22—All rings being cycloaliphatic the ring system containing eight carbon atoms, e.g. pentalene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/30—Monomer units or repeat units incorporating structural elements in the main chain
- C08G2261/33—Monomer units or repeat units incorporating structural elements in the main chain incorporating non-aromatic structural elements in the main chain
- C08G2261/332—Monomer units or repeat units incorporating structural elements in the main chain incorporating non-aromatic structural elements in the main chain containing only carbon atoms
- C08G2261/3325—Monomer units or repeat units incorporating structural elements in the main chain incorporating non-aromatic structural elements in the main chain containing only carbon atoms derived from other polycyclic systems
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/40—Polymerisation processes
- C08G2261/41—Organometallic coupling reactions
- C08G2261/418—Ring opening metathesis polymerisation [ROMP]
Definitions
- the present invention relates to the provision of ruthenium complexes, their manufacture and uses for example in catalysis, in particular in olefin metathesis reactions, including in Ring Opening Metathesis Polymerisation (ROMP).
- ruthenium complexes their manufacture and uses for example in catalysis, in particular in olefin metathesis reactions, including in Ring Opening Metathesis Polymerisation (ROMP).
- EMP Ring Opening Metathesis Polymerisation
- Olefin metathesis is considered as one of the most useful tools in organic chemistry. Since Grubbs reported the first generation ruthenium-catalyst (ref 1), numerous studies have been aimed at developing long life and more active catalysts and precatalysts. A breakthrough was the replacement of a phosphine ligand by a N-heterocyclic carbene (NHC), increasing the reactivity and stability of the corresponding complex (ref 2). See G-II in Scheme 1 below where PCy 3 is tricyclohexylphosphine. Additional modifications afforded so-called boomerang-type catalysts, the most well-known being Hoveyda's catalyst (Hov-II in scheme 1 below) (refs 3,4).
- Hov-II Hov-II in scheme 1 below
- cationic ruthenium complexes are known for use as catalysts and are shown in Scheme 1a below.
- Furstner and Dixneuf have described 18-electron cationic allenylidene Ru complexes such as (a) below that were found to be catalyst precursors for ring closing metathesis (RCM).
- Hofmann describes dinuclear 16-electron cationic ruthenium complexes with chelating bisphosphane ligands (b), displaying activity in ring opening metathesis polymerisation (ROMP).
- Kurosawa et al (ref 9) describe 18-electron cationic ruthenium complexes (c) made by chloride abstraction using silver salts.
- the present invention provides a cis ruthenium complex according to general formula I:
- Groups R 3 ,R 4 ,R 5 may be substituted, for example once, twice, or three times, e.g. once, i.e. formally replacing one or more hydrogen atoms of the alkyl, aryl or heteroaryl group.
- substituents when are halo (e.g. fluoro, chloro, bromo and iodo), SF 5 , CF 3 , aryl, aryl hydroxy, nitro, amino, alkoxy, alkylthio, carboxy, cyano, thio, formyl, ester, acyl, thioacyl, amido, sulfonamido, carbamate and the like.
- substituent is amino it may be NH 2 , NHR or NR 2 , where the substituents R on the nitrogen may be alkyl, aryl or heteroaryl (for example substituted or unsubstituted C1-C20 or even C1-C10).
- Exemplary R 3 ,R 4 ,R 5 aryl substituents include phenyl or naphthyl that may be substituted.
- Exemplary R 3 ,R 4 ,R 5 heteroaryl substituents include pyridinyl, furanyl, pyrrolyl and pyrimidinyl.
- heteroaromatic rings include pyridazinyl (in which 2 nitrogen atoms are adjacent in an aromatic 6-membered ring); pyrazinyl (in which 2 nitrogens are 1,4-disposed in a 6-membered aromatic ring); pyrimidinyl (in which 2 nitrogen atoms are 1,3-disposed in a 6-membered aromatic ring); or 1,3,5-triazinyl (in which 3 nitrogen atoms are 1,3,5-disposed in a 6-membered aromatic ring).
- the complexes of formula I are of a generally square pyramidal structure and are cis in the sense that the groups A and Z are adjacent to each other, whilst the two groups X are adjacent to each other.
- cis Ru complexes have previously been described (refs 12, 13), but all have a chelating ligand present in the structure.
- group Z is replaced with a moiety that coordinates to Ru via a heteroatom (e.g. O,N,S) that is covalently joined to the alkylidene (carbene) moiety double bonded to the Ru to form an alkylidene chelating ligand.
- a bidendate diphosphine ligand may be used. Examples of prior art cis dichloride structures are shown below.
- the cis complexes of the present invention have monodentate groups Z.
- the complexes of the invention are useful catalysts as described below. By providing complexes without bidentate A-Z ligands (for example alkylidene) or bidentate diphosphine ligands, greater opportunity is afforded to tune the behaviour of the catalyst as the groups A and Z can each be changed independently.
- trans complex M1 A number of trans complexes such as complex M1 below where both A and Z are phosphine are already known, as are trans complexes GII and M2 where Z is a phosphine and A is an NHC.
- cis structure I is to be understood to include structure Ia.
- isomerism is possible, for example where R 1 and R 2 are different or are fused to form a ring that is not symmetrical then geometric isomerism about the carbon to ruthenium double bond may occur.
- the anionic ligands X may be, for example, independently selected from the group consisting of halogen (I, Br, Cl, F), benzoate, C 1 -C 5 carboxylates (for example CF 3 CO 2 , CH 3 CO 2 , CFH 2 CO 2 , pivalate), C 1 -C 5 alkoxy (for example, MeO, EtO, (CH 3 ) 3 CO, (CF 3 ) 3 CO, (CF 3 ) 2 (CH 3 )CO, (CF 3 )(CH 3 ) 2 CO) phenoxy, C 1 -C 5 alkyl thio groups, tosylate, mesylate, brosylate, trifluoromethane sulfonate, phenylacetate and pseudo-halogens (for example cyanide, thiocyanate, isothiocyanate, selenocyanate).
- halogen I, Br, Cl, F
- benzoate C 1 -C 5 carboxylates
- both anions X are chloride.
- ligands X can be fused to each other, forming a bidendate anionic ligand. For instance, acac (acetylacetonate).
- ligands affords the opportunity to tune each of the substituents on the complex for its intended uses e.g. as a catalyst.
- Y ⁇ or Y 2 ⁇ are non-coordinating ionic ligands that may be the same or different for each occurrence.
- the non-coordinating anionic ligands Y ⁇ may be selected from the group consisting of SbF 6 ⁇ , BF 4 ⁇ , PF 6 ⁇ , ClO 4 ⁇ , [B[3,5-(CF 3 ) 2 C 6 H 3 ] 4 ] ⁇ and BPh 4 ⁇ .
- the non-coordinating anionic ligands Y 2 ⁇ may be selected from the group consisting of Oxide (O 2 ⁇ ), Hydrogen phosphate (HPO 4 2 ⁇ ), Sulfide (S 2 ⁇ ), Chromate (CrO 4 2 ⁇ ), Sulfate (SO 4 2 ⁇ ), Dichromate (Cr 2 O 7 2 ⁇ ), Thiosulfate (S 2 O 3 2 ⁇ ), Carbonate (CO 3 2 ⁇ ), Sulfite (SO 3 2 ⁇ ), Oxalate (C 2 O 4 2 ⁇ ) and Peroxide (O 2 2 ⁇ ).
- complexes of formulas VIII, IX or X may have vacant positions about the Ru metal centre occupied by a neutral ligand such as a solvent molecule.
- a neutral ligand such as a solvent molecule.
- pyridine or acetonitrile as shown hereafter with reference to a specific complex.
- complexes of the forms shown below, where W is a neutral ligand can be formed.
- R 1 and R 2 may be H and aryl (for example phenyl or substituted phenyl)
- the ring may have another ring fused to it, for example to form an indenylidene moiety.
- the indenylidene moiety may be substituted, for example a 3-phenylindenylidene moiety such as employed in M2 of Scheme 1 (above).
- the group Z is phosphite i.e.
- group Z is a phosphite group
- examples include P(OMe) 3 P(OEt) 3 , P(O i Pr) 3 and P(OPh) 3 .
- the groups R 3 ,R 4 ,R 5 may be substituted.
- variation of the substituents R 3 ,R 4 ,R 5 of groups Z, in particular phosphite groups Z can provide useful adjustment of the properties of the complexes described herein.
- Z is P(OPh) 3 the properties of the complex as a catalyst may be adjusted by substituents on the phenyl ring.
- Examples of combinations of A and Z for the complexes described herein, where Z is phosphite, include nucleophilic carbene (in particular N-heterocyclic carbene)/phosphite, phosphine/phosphite and phosphite/phosphite.
- group A as a phosphine examples include PCy 3 and PPh 3 —where Cy is cyclohexyl and Ph is phenyl.
- group A as a phosphite examples include P(OMe) 3 P(OEt) 3 , P(O i Pr) 3 and P(OPh) 3 .
- the carbene may have a four, five, six or seven membered ring containing the carbene carbon. Typically a five-membered ring.
- the nucleophilic carbene may be an N-heterocyclic carbene (NHC).
- the NHC employed may be saturated or unsaturated and may contain one or more nitrogen atoms and optionally may contain other heteroatoms (such as O and S) in the ring.
- the ligand may have the form above wherein the groups R 6 may be the same or different, the groups R 7 where present may be the same or different and the dashed line in the ring represents optional unsaturation.
- One or more of the carbon atoms in the ring (apart from the carbene carbon) may be substituted with O or S.
- Each R 6 and R 7 may be, independently for each occurrence, selected from: H, a primary or secondary alkyl group (for example C1-C10 or even C1-C4) that may be substituted or unsubstituted, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, or substituted or unsubstituted anthracenyl, or a functional group selected from the group consisting of halo, hydroxyl, sulfhydryl, cyano, cyanato, thiocyanato, amino, nitro, nitroso, sulfo, sulfonato, boryl, borono, phosphono, phosphonato, phosphinato, phospho, phosphino, and silyloxy.
- a primary or secondary alkyl group for example C1-C10 or even C1-C4
- a functional group selected from the group consisting of halo,
- NHC carbene ligands bearing two nitrogen atoms in the ring each adjacent the carbene carbon may be employed.
- the NHC carbene ligands of this type may have the form:
- each of the groups R 6 , R 7 and R 8 may be the same or different for each occurrence and the dashed line in the ring represents optional unsaturation, wherein R 7 is absent.
- Each R 6 , R 7 and R 8 may be, independently for each occurrence, selected from: H, a primary or secondary alkyl group (for example C1-C10 or even C1-C4) that may be substituted or unsubstituted, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, or substituted or unsubstituted anthracenyl, or a functional group selected from the group consisting of halo, hydroxyl, sulfhydryl, cyano, cyanato, thiocyanato, amino, nitro, nitroso, sulfo, sulfonato, boryl, borono, phosphono, phosphonato, phosphinato, phospho, pho
- the groups R 8 may be substituted or unsubstituted aromatic rings that may be heterocyclic aromatic rings.
- Substituents R 6 , R 7 and R 8 in the structures above may include alkyl and unsaturated alkyl groups, aryl groups that may be substituted and may contain heteroatoms.
- NHC carbene ligands include those according to formulas III to VI below:
- each group R 9 , R 10 and R 11 is independently for each occurrence selected from: H, a primary or secondary alkyl group (for example C1-C10 or even C1-C4) that may be substituted or unsubstituted, substituted or unsubstituted phenyl, substituted or unsubstituted naphtyl, or substituted or unsubstituted anthracenyl, or a functional group selected from the group consisting of halo, hydroxyl, sulfhydryl, cyano, cyanato, thiocyanato, amino, nitro, nitroso, sulfo, sulfonato, boryl, borono, phosphono, phosphonato, phosphinato, phospho, phosphino, and silyloxy; R 12 , R 13 , R 14 and R 15 are each independently for each occurrence H, a substituted or unsubstituted alkyl group
- NHC carbene family for the formation of the ruthenium complexes, the alkyl substituted aromatic rings providing additional stabilisation to the carbene lone pair of electrons.
- the desired ruthenium phosphite complexes may be made by substitution of a suitable leaving group from a precursor ruthenium complex. For example from 1 in Scheme 2 below, (wherein SIMes is the NHC:
- complex 1 was reacted with different phosphites (1 equiv) in dichloromethane and stirred for 1 h at room temperature.
- This procedure can produce a mixture of two complexes, each presenting 31 P NMR shifts corresponding to chelated phosphites—between 110 and 135 ppm (free phosphites have signals around 128-145 ppm).
- the two complexes have been shown to be cis and trans forms as shown for the example using P(O i Pr) 3 (complexes 2) of Scheme 2 and discussed hereafter with reference to specific examples.
- the trans form (phosphite opposite to NHC) is kinetically favoured compared to the cis form (phosphite adjacent the NHC) which is the thermodynamic product.
- the trans form is produced in higher yield than the thermodynamically more stable cis at lower temperatures.
- the trans form is readily converted to the cis by heat as indicated in Scheme 2.
- the present invention provides a method of preparing a ruthenium complex according to general formula I:
- L is a leaving group and A,X, R 1 and R 2 have the same meaning as before;
- the leaving group L may be for example a substituted or unsubstituted pyridine, phosphine, phosphite, phosphinite, phosphonite, phosphoramidate, thiophene, tetrahydrofuran, N heterocyclic carbene, acetonitrile or benzonitrile.
- the leaving group L may be linked covalently to the group
- the method may further comprise heating to convert trans complex (formula II) to cis complex (formula I).
- the method can make complexes of formula II as well as those of formula I.
- a suitable solvent typically a chlorinated solvent such as dichloromethane.
- Thermal conversion of a trans complex to a cis complex may be accomplished by heating in a suitable solvent such as, for example chloroform, toluene or nitromethane.
- Complexes of formulas VIII and IX may be made, for example by starting with a complex of formula I or formula II and displacing one of the coordinating ligands X.
- X is halogen reaction with a silver salt of the anion Y ⁇ (e.g. AgSbF 6 ) can produce the products of formula VIII, or X.
- the method is illustrated in Scheme 3 below, where anionic ligand X is chloride in this example.
- reaction of an example complex of formula I where X is chloride with two equivalents of AgSbF 6 did not produce a complex of formula IX, but rather a complex of formula X wherein one chloride was retained on the ruthenium, which was oxidised to the Ru III species shown.
- the method of preparing these cationic Ru complexes is another aspect of the present invention.
- the complexes described herein can be used as catalysts.
- trans complexes of formula II can show good catalytic activity at room temperature but the cis form (formula I) generally requires higher temperatures, suggesting that the cis form is a latent catalyst.
- the trans form may be preferred in low temperature situations but as shown below at even moderate temperatures high conversion rates can be obtained when using the cis form.
- the cis forms of the complexes are robust at elevated temperature, showing reduced tendency to loss of activity with time.
- the complexes may be used to catalyse a reaction selected from the group consisting of, for example, ring closing metathesis (RCM), enyne ring closing metathesis (enyne RCM), cross metathesis (CM) and ring opening polymerisation metathesis (ROMP). Results obtained are discussed hereafter and with reference to specific examples.
- RCM ring closing metathesis
- enyne RCM enyne ring closing metathesis
- CM cross metathesis
- ROMP ring opening polymerisation metathesis
- ROMP products are generally prepared by Reaction Injection Moulding (RIM) where the monomer, catalyst and any other components are injected into a mould under high pressure. On reaction a solid, moulded, product is prepared.
- RIM Reaction Injection Moulding
- the monomer and any other components can be loaded into a mould (under pressure if required), with the catalyst already dissolved or dispersed within the monomer etc if desired.
- a small quantity of a suitable solvent for example a chlorinated solvent such as dichloromethane may be employed to provide a solution of the catalyst.
- Reaction can then be initiated in a controlled fashion by heating to an appropriate temperature as described hereafter with reference to specific embodiments. Typically temperatures in the range 30° C. to 120° C. or even 40° C. to 100° C. may be utilised. These relatively low reaction temperatures are convenient as monomers such as dicyclopentadiene have low boiling points
- a procedure including mixing the catalyst into the monomer mixture as it is introduced into a mould may be used.
- catalyst loadings of the order of 1 to 100 ppm in relation to monomer or even 5 to 60 ppm may be successfully employed in ROMP procedures making use of complexes of the invention as catalysts.
- ROMP using catalysts of the invention may be performed using as monomer any of the ring systems already known to undergo such processes.
- Suitable monomers for use in ROMP with the catalysts can include dicyclopentadiene, norbornene, norbornadiene, cyclooctadiene and derivatives, such as substituted derivatives of these monomers, thereof. Mixtures of monomers may also be employed and/or other components such as reinforcing fibres and fillers as known to those skilled in the art.
- NHC carbene is provided as group A and a phosphite is provided as group Z have been shown to be suitable for use in ROMP polymerisation.
- the NHC carbene may be selected from those described herein above, for example it may be one of:
- NHC is SIPr and A is a phosphite
- A is tri-isopropyl phosphite as described hereafter and with reference to a particular example of a trans complex showing latent catalyst behaviour.
- FIGS. 1 a to 1 d show X-ray structures of complexes of the invention
- FIG. 2 shows graphically trans to cis isomerisation of complexes of the invention
- FIG. 3 shows graphically trans to cis isomerisation of complexes of the invention.
- FIG. 4 shows graphically results of ring closure metathesis experiments using various catalysts.
- cis-2 is a black solid completely insoluble in pentane, indicating a dependence of physical properties to spatial arrangement.
- the structure of cis-2 has been confirmed by X-ray crystallography, following growth of a suitable crystal from CH 2 Cl 2 /n-dodecane. (See FIG. 1 b ).
- the X-ray data also show that the complex cis-2 is present as a pair of enantiomers as discussed above.
- 6- and 7-membered rings 19 and 21 were obtained in respectively 96 and 87% yield, and no increase in reaction time compared to 5-membered ring 15 (entries 4 & 5). Of note, a dilution to 0.05M was necessary to obtain 21 without observing parallel formation of polymers.
- RCM cyano analogues 24 and 26 (entries 6 & 7).
- Non-hindered cyclopentene 23 was isolated in good yield (88%), indicating that the presence of potentially chelating cyano groups was not detrimental to catalysis. Nevertheless, cis-2 was unable to promote the formation of 25, the starting material remaining unreacted. Tosylamine-based olefins were next investigated.
- FIG. 4 shows RCM of compound 30 (table 4 entry 11) in toluene at 80° C. carried out with a range of Ru complexes.
- Trans or cis-2 both rapidly produce a high conversion whereas prior art complexes Hov-II, G-II, M2 (structures shown in Scheme 1) and M31 (which is the pyridine complex 1 in scheme 2) did not produce any better than about 60% conversion (complex M2) under these conditions.
- Enyne ring closing metathesis is a powerful tool to synthesize dienes that can undergo further Diels-Alder reaction and thus furnish bicyclic compounds readily.
- Easy substrates 10 and 44 were fully converted after 30 minutes, albeit 11 was only isolated in 75% yield (Table 5 below, entries 1 & 2).
- a longer reaction time was necessary to convert hindered compound 46 (entry 3).
- a relatively low isolated yield of 71% was obtained; such behaviour could result from parallel polymerisation reactions that can easily occur at elevated temperature.
- substrate 48 remained unchanged after 24 h of reaction, the more hindered enyne 50 was efficiently cyclized in 3 h (entries 4 & 5). Addition of ethylene is known to be necessary to allow reaction in the case of terminal alkynes such as 48.
- catalyst cis-2 allowed the formation of dienes from enynes in a short reaction time and acceptable yields.
- the complex cis-2 was reacted at room temperature with one equivalent of silver hexafluoroantimonate, yielding the pure complex 63, after simple removal of salts by filtration on celite.
- the structure of 63 was confirmed by X-ray crystallography.
- Complex 63 may be converted into an acetonitrile containing species 63a as below:
- 63 (77.0 mg, 0.071 mmol) was dissolved in 1 mL of acetonitrile and the mixture was stirred for fifteen minutes. Solvent was removed in vacuo. The black solid was washed with hexane yielding 63a (99%).
- the catalytic potential of 63 was first assessed for the RCM (ring closing metathesis) of the challenging tosylamine derivative 30 (Table 7) at a low catalyst loading (0.1 mol % Ru).
- the catalytic potential of 63 was than investigated for a range of dienes and enynes, under these harsh reaction conditions: 140° C., 15 min (Table 8).
- a cis complex 68 comprising a phosphine and a phosphite as ligands A and Z can be made as follows:
- the cis complexes 70a to 70e feature various para substituents on the phenyl rings of the phosphite ligands. These variations in the phosphite ligand can be employed to adjust catalytic activity.
- the NHC ligand may be altered to amend catalyst behaviour.
- providing bulkier ligands on the NHC can promote higher catalytic activity.
- the provision of bulkier alkyl substituents on the aromatic rings of imidazole based NHC ligands can impart improved catalyst behaviour.
- complex 72 prepared as shown below from the known pyridine containing complex 71 performs well in ROMP experiments.
- Complex 72 is prepared in a trans form as shown below, but it has been shown to behave as a latent catalyst, in particular in ROMP reactions.
- Substantial polymerisation did not occur at room temperature, showing the latency of the catalyst. However, the mixtures can form a gel at room temperature indicating some initiation of polymerisation. Heating at temperatures between 40 and 100° C. was required to provide full polymerisation. Thus a smooth controlled polymerisation could be carried out, without e.g. boiling off of the monomer due to an exotherm.
- the amount of catalyst used varied between 5 to 60 ppm, based on amount of monomer.
- complexes including cis complexes such cis-2 described before also provided polydicyclopentadiene by the procedure described above.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
Abstract
Cis and trans ruthenium complexes that can be used as catalysts for ring opening metathesis polymerisation (ROMP) are described. The complexes are generally square pyramidal in nature, having two anionic ligands X. Corresponding cationic complexes where one or both of the anionic ligands X are replaced by a non-co-ordinating anionic ligand are also described. Polymers such as polydicyclopentadiene (PDCPD) can be prepared using the catalysts.
Description
- This application is a continuation application of U.S. patent application Ser. No. 14/348,407, filed Mar. 28, 2014, now U.S. Pat. No. 9,815,765, Knors which was filed under the provisions of 35 U.S.C. § 371 and claims the benefit of priority from International Patent Application No. PCT/GB2012/000744 filed Sep. 28, 2012, which claims the benefit of priority from UK Patent Application No. 1116719.4 filed Sep. 28, 2011, the contents of all of which are incorporated herein by reference.
- The work leading to this invention has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7-NMP-2007-SMALL-1) “EUMET”/ERC grant agreement no. NMP2-SL-2009-211468.
- The present invention relates to the provision of ruthenium complexes, their manufacture and uses for example in catalysis, in particular in olefin metathesis reactions, including in Ring Opening Metathesis Polymerisation (ROMP).
- Olefin metathesis is considered as one of the most useful tools in organic chemistry. Since Grubbs reported the first generation ruthenium-catalyst (ref 1), numerous studies have been aimed at developing long life and more active catalysts and precatalysts. A breakthrough was the replacement of a phosphine ligand by a N-heterocyclic carbene (NHC), increasing the reactivity and stability of the corresponding complex (ref 2). See G-II in
Scheme 1 below where PCy3 is tricyclohexylphosphine. Additional modifications afforded so-called boomerang-type catalysts, the most well-known being Hoveyda's catalyst (Hov-II inscheme 1 below) (refs 3,4). In such catalysts the benzylidene bears a donor atom that binds to Ru and decoordinates during catalysis to recoordinate after. More recently, replacing the benzylidene group of Grubbs original catalysts by an indenylidene moiety resulted in highly stable catalysts (for example M2 inscheme 1 where PCy3 is tricyclohexylphosphine) (ref 5). - This family of catalysts has proved its efficiency in various metathesis transformations, and studies on the variation of the NHC group have already been reported (ref 6).
- Other examples of Ruthenium catalysts for use in metathesis transformations are described in U.S. Pat. No. 7,622,590.
- Some cationic ruthenium complexes are known for use as catalysts and are shown in Scheme 1a below. For example Furstner and Dixneuf (ref 7) have described 18-electron cationic allenylidene Ru complexes such as (a) below that were found to be catalyst precursors for ring closing metathesis (RCM). Hofmann (ref 8) describes dinuclear 16-electron cationic ruthenium complexes with chelating bisphosphane ligands (b), displaying activity in ring opening metathesis polymerisation (ROMP). Kurosawa et al (ref 9) describe 18-electron cationic ruthenium complexes (c) made by chloride abstraction using silver salts. A latent cationic ruthenium NHC-based pre-catalyst (d) with excellent ROMP properties activated by UV irradiation has also been reported (ref 10). Complexes (e) are described by Romero et al (ref 11).
- In view of the importance of olefin metathesis chemistry there remains the need to provide yet further metathesis catalysts. Some further catalysts are described in an earlier application (PCT/GB2011/000404) by the same inventor as the present application, the entire contents of which are incorporated by reference herein.
- According to a first aspect the present invention provides a cis ruthenium complex according to general formula I:
-
- wherein for each occurrence the groups X are the same or different and are anionic ligands or are fused to form a bidentate ligand;
- the groups R1 and R2 are the same or different and are selected from the group consisting of hydrogen, C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, C2-C20 alkoxycarbonyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C1-C20 alkylthio, C1-C20 alkylsulfonyl, and C1-C20 alkylsulfinyl, each R1 and R2 optionally being substituted (for example with C1-C5 alkyl, halogen, C1-C10 alkoxy, or with a phenyl group that may itself be substituted, for example with halogen, C1-C5 alkyl or C1-C5 alkoxy); or
- the groups R1 and R2 are fused together to form a ring (for example C4-C10, or even C5-C6) that may be substituted or unsubstituted, saturated or unsaturated and may be fused to a further ring (for example C4-C10 or even C5-C6); and
the group Z is selected from the group consisting of:
-
- wherein the groups R3, R4 and R5 are each independently for each occurrence selected from the group consisting of substituted or unsubstituted primary, secondary or tertiary alkyl, that may be cyclic and may be unsaturated (for example C1-C10 or even C1-C4); substituted or unsubstituted aryl or heteroaryl; optionally two or more of the groups R3, R4 and R5 are fused to form a ring; and
- the group A is selected from the group consisting of a nucleophilic carbene, and a phosphorus ligand independently selected from the list of groups as defined for group Z; and with the proviso that when A is a nucleophilic carbene, Z is not
- Groups R3,R4,R5 may be substituted, for example once, twice, or three times, e.g. once, i.e. formally replacing one or more hydrogen atoms of the alkyl, aryl or heteroaryl group. Examples of such substituents when are halo (e.g. fluoro, chloro, bromo and iodo), SF5, CF3, aryl, aryl hydroxy, nitro, amino, alkoxy, alkylthio, carboxy, cyano, thio, formyl, ester, acyl, thioacyl, amido, sulfonamido, carbamate and the like. Where the substituent is amino it may be NH2, NHR or NR2, where the substituents R on the nitrogen may be alkyl, aryl or heteroaryl (for example substituted or unsubstituted C1-C20 or even C1-C10).
- Where the groups R3,R4,R5 are cycloalkyl they may be for example cyclohexyl or cyclopentyl. The cyclohexyl or cyclopentyl groups if present may be saturated or unsaturated and may be substituted as described above. By aryl is meant herein a radical formed formally by abstraction of a hydrogen atom from an aromatic compound. As known to those skilled in the art, heteroaryl moieties are a subset of aryl moieties that comprise one or more heteroatoms, typically O, N or S, in place of one or more carbon atoms and any hydrogen atoms attached thereto. Exemplary R3,R4,R5 aryl substituents, for example, include phenyl or naphthyl that may be substituted. Exemplary R3,R4,R5 heteroaryl substituents, for example, include pyridinyl, furanyl, pyrrolyl and pyrimidinyl. Further examples of heteroaromatic rings include pyridazinyl (in which 2 nitrogen atoms are adjacent in an aromatic 6-membered ring); pyrazinyl (in which 2 nitrogens are 1,4-disposed in a 6-membered aromatic ring); pyrimidinyl (in which 2 nitrogen atoms are 1,3-disposed in a 6-membered aromatic ring); or 1,3,5-triazinyl (in which 3 nitrogen atoms are 1,3,5-disposed in a 6-membered aromatic ring).
- The complexes of formula I are of a generally square pyramidal structure and are cis in the sense that the groups A and Z are adjacent to each other, whilst the two groups X are adjacent to each other.
- In the complexes of the invention the groups Z (and A when A is a phosphorus ligand) bond to Ru by the phosphorus atom. An example of a cis complex where A is a nucleophilic carbene and Z is a phosphine (tricylohexylphosphine—PCy3) is known (ref 12) as shown below.
- A small number of related cis Ru complexes have previously been described (
refs 12, 13), but all have a chelating ligand present in the structure. For example the group Z is replaced with a moiety that coordinates to Ru via a heteroatom (e.g. O,N,S) that is covalently joined to the alkylidene (carbene) moiety double bonded to the Ru to form an alkylidene chelating ligand. Alternatively a bidendate diphosphine ligand may be used. Examples of prior art cis dichloride structures are shown below. - In contrast the cis complexes of the present invention have monodentate groups Z. The complexes of the invention are useful catalysts as described below. By providing complexes without bidentate A-Z ligands (for example alkylidene) or bidentate diphosphine ligands, greater opportunity is afforded to tune the behaviour of the catalyst as the groups A and Z can each be changed independently.
- The trans complexes of formula II shown below where A,Z, R1 and R2 have the same meaning as in formula I constitute a second aspect of the present invention, with the provisos that both groups Z and A are not phosphine;
- and where A is a nucleophilic carbene, Z is not a phosphine:
- A number of trans complexes such as complex M1 below where both A and Z are phosphine are already known, as are trans complexes GII and M2 where Z is a phosphine and A is an NHC.
- The trans complexes have groups X opposite each other and groups A and Z opposite each other.
- It will be appreciated that further isomerism is possible for both the cis and trans forms (formulas I and II). For example enantiomeric pairs may be produced as a consequence of the square pyramidal geometry. For example the enantiomeric pair of cis isomers I and Ia below.
- In this description of the invention it is to be understood that structures drawn define the cis or trans positioning of the groups A, Z and X but otherwise a given structure includes all possible isomers. Thus cis structure I is to be understood to include structure Ia. Further isomerism is possible, for example where R1 and R2 are different or are fused to form a ring that is not symmetrical then geometric isomerism about the carbon to ruthenium double bond may occur.
- In the cis and trans complexes of the invention the anionic ligands X may be, for example, independently selected from the group consisting of halogen (I, Br, Cl, F), benzoate, C1-C5 carboxylates (for example CF3CO2, CH3CO2, CFH2CO2, pivalate), C1-C5 alkoxy (for example, MeO, EtO, (CH3)3CO, (CF3)3CO, (CF3)2(CH3)CO, (CF3)(CH3)2CO) phenoxy, C1-C5 alkyl thio groups, tosylate, mesylate, brosylate, trifluoromethane sulfonate, phenylacetate and pseudo-halogens (for example cyanide, thiocyanate, isothiocyanate, selenocyanate).
- In particular embodiments, both anions X are chloride. Alternatively ligands X can be fused to each other, forming a bidendate anionic ligand. For instance, acac (acetylacetonate).
- As an alternative one or both of the groups X in formulas I or II above may be replaced by a non-co-ordinating anionic ligand to provide cationic ruthenium complexes of formula VIII, IX or X:
- wherein groups R1, R2, A and Z have the same meaning as described above in respect of Formulas I and II but without the provisos attached to the definitions. Complexes of formula X have an Ru (III) metal centre to balance the charge provided by the remaining anionic co-ordinating ligand X and the non-co-ordinating anionic ligand(s) Y− or Y2−.
- A cationic complex making use of phosphite and NHC ligands has been described (ref 14) but only when making use of a bidentate ligand (the group
- includes an ester). The structure is given below.
- As described above with respect to complexes of formula I, the use of monodentate Z, A and
- ligands affords the opportunity to tune each of the substituents on the complex for its intended uses e.g. as a catalyst.
- Y− or Y2− are non-coordinating ionic ligands that may be the same or different for each occurrence. The non-coordinating anionic ligands Y− may be selected from the group consisting of SbF6 −, BF4 −, PF6 −, ClO4 −, [B[3,5-(CF3)2C6H3]4]− and BPh4 −. The non-coordinating anionic ligands Y2− may be selected from the group consisting of Oxide (O2−), Hydrogen phosphate (HPO4 2−), Sulfide (S2−), Chromate (CrO4 2−), Sulfate (SO4 2−), Dichromate (Cr2O7 2−), Thiosulfate (S2O3 2−), Carbonate (CO3 2−), Sulfite (SO3 2−), Oxalate (C2O4 2−) and Peroxide (O2 2−).
- In some instances complexes of formulas VIII, IX or X may have vacant positions about the Ru metal centre occupied by a neutral ligand such as a solvent molecule. For example pyridine or acetonitrile as shown hereafter with reference to a specific complex. Thus, for example, complexes of the forms shown below, where W is a neutral ligand can be formed.
- As for formulas I and II (discussed above) isomerism is possible with some of these complexes and the formulas VIII and IX (including those with neutral ligands—W) as shown should be understood to include all possible isomers. For example the complex VIII may exist in two optical isomeric forms VIII and Villa below and the structure VIII should be understood to include either or both these possibilities as well as geometric isomers such as VIIIb.
- For any of formulas I, II, VIII, IX and X the groups R1 and R2 may be H and aryl (for example phenyl or substituted phenyl)
- Where the groups R1 and R2 are fused to form a ring, the ring may have another ring fused to it, for example to form an indenylidene moiety. The indenylidene moiety may be substituted, for example a 3-phenylindenylidene moiety such as employed in M2 of Scheme 1 (above).
- Advantageously in the complexes described herein the group Z is phosphite i.e.
- Where the group Z is a phosphite group:
- examples include P(OMe)3 P(OEt)3, P(OiPr)3 and P(OPh)3. As described above the groups R3,R4,R5 may be substituted. For use as catalysts, variation of the substituents R3,R4,R5 of groups Z, in particular phosphite groups Z, can provide useful adjustment of the properties of the complexes described herein. For example where Z is P(OPh)3 the properties of the complex as a catalyst may be adjusted by substituents on the phenyl ring.
- Examples of combinations of A and Z for the complexes described herein, where Z is phosphite, include nucleophilic carbene (in particular N-heterocyclic carbene)/phosphite, phosphine/phosphite and phosphite/phosphite.
- Examples of group A as a phosphine include PCy3 and PPh3—where Cy is cyclohexyl and Ph is phenyl. Examples of group A as a phosphite include P(OMe)3 P(OEt)3, P(OiPr)3 and P(OPh)3.
- Where the group A is an nucleophilic carbene, the carbene may have a four, five, six or seven membered ring containing the carbene carbon. Typically a five-membered ring. The nucleophilic carbene may be an N-heterocyclic carbene (NHC).
- The NHC employed may be saturated or unsaturated and may contain one or more nitrogen atoms and optionally may contain other heteroatoms (such as O and S) in the ring.
- For example the ligand may have the form above wherein the groups R6 may be the same or different, the groups R7 where present may be the same or different and the dashed line in the ring represents optional unsaturation. One or more of the carbon atoms in the ring (apart from the carbene carbon) may be substituted with O or S. Each R6 and R7 may be, independently for each occurrence, selected from: H, a primary or secondary alkyl group (for example C1-C10 or even C1-C4) that may be substituted or unsubstituted, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, or substituted or unsubstituted anthracenyl, or a functional group selected from the group consisting of halo, hydroxyl, sulfhydryl, cyano, cyanato, thiocyanato, amino, nitro, nitroso, sulfo, sulfonato, boryl, borono, phosphono, phosphonato, phosphinato, phospho, phosphino, and silyloxy.
- Advantageously NHC ligands bearing two nitrogen atoms in the ring, each adjacent the carbene carbon may be employed. The NHC carbene ligands of this type may have the form:
- wherein each of the groups R6, R7 and R8 may be the same or different for each occurrence and the dashed line in the ring represents optional unsaturation, wherein R7 is absent. Each R6, R7 and R8 may be, independently for each occurrence, selected from: H, a primary or secondary alkyl group (for example C1-C10 or even C1-C4) that may be substituted or unsubstituted, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, or substituted or unsubstituted anthracenyl, or a functional group selected from the group consisting of halo, hydroxyl, sulfhydryl, cyano, cyanato, thiocyanato, amino, nitro, nitroso, sulfo, sulfonato, boryl, borono, phosphono, phosphonato, phosphinato, phospho, phosphino, and silyloxy.
- Advantageously the groups R8 may be substituted or unsubstituted aromatic rings that may be heterocyclic aromatic rings. Substituents R6, R7 and R8 in the structures above may include alkyl and unsaturated alkyl groups, aryl groups that may be substituted and may contain heteroatoms.
- Suitable examples of NHC carbene ligands include those according to formulas III to VI below:
- wherein each group R9, R10 and R11, is independently for each occurrence selected from: H, a primary or secondary alkyl group (for example C1-C10 or even C1-C4) that may be substituted or unsubstituted, substituted or unsubstituted phenyl, substituted or unsubstituted naphtyl, or substituted or unsubstituted anthracenyl, or a functional group selected from the group consisting of halo, hydroxyl, sulfhydryl, cyano, cyanato, thiocyanato, amino, nitro, nitroso, sulfo, sulfonato, boryl, borono, phosphono, phosphonato, phosphinato, phospho, phosphino, and silyloxy;
R12, R13, R14 and R15 are each independently for each occurrence H, a substituted or unsubstituted alkyl group (for example C1-C10 or even C1-C4), substituted or unsubstituted aryl, or in formulas (IV) and (VI) together with the carbons carrying them form a substituted or unsubstituted, fused 4-8 membered carbocylic ring or a substituted or unsubstituted, fused aromatic ring, preferably a fused phenyl ring; and
R16 is alkyl (for example C1-C10 or even C1-C4) or a cycloalkyl (for example C3-C8). - For example these NHC carbenes:
- are suitable examples of the NHC carbene family for the formation of the ruthenium complexes, the alkyl substituted aromatic rings providing additional stabilisation to the carbene lone pair of electrons.
- The desired ruthenium phosphite complexes may be made by substitution of a suitable leaving group from a precursor ruthenium complex. For example from 1 in Scheme 2 below, (wherein SIMes is the NHC:
- by a route analogous to that used for the production of ruthenium phosphine complexes.
- For example, complex 1 was reacted with different phosphites (1 equiv) in dichloromethane and stirred for 1 h at room temperature. This procedure can produce a mixture of two complexes, each presenting 31P NMR shifts corresponding to chelated phosphites—between 110 and 135 ppm (free phosphites have signals around 128-145 ppm). The two complexes have been shown to be cis and trans forms as shown for the example using P(OiPr)3 (complexes 2) of
Scheme 2 and discussed hereafter with reference to specific examples. - The trans form (phosphite opposite to NHC) is kinetically favoured compared to the cis form (phosphite adjacent the NHC) which is the thermodynamic product. Thus the trans form is produced in higher yield than the thermodynamically more stable cis at lower temperatures. The trans form is readily converted to the cis by heat as indicated in
Scheme 2. - X-ray studies of cis-2 have shown that it was actually produced as a mixture of two enantiomers as indicated below.
- According to a third aspect the present invention provides a method of preparing a ruthenium complex according to general formula I:
- wherein the groups A,X,Z, R1 and R2 have the same meaning as before, the method comprising:
- providing a complex according to general formula VII: X VII
- where L is a leaving group and A,X, R1 and R2 have the same meaning as before; and
- reacting the complex of formula VII with a compound comprising or consisting of a group Z wherein Z has the same meaning as before.
- The leaving group L may be for example a substituted or unsubstituted pyridine, phosphine, phosphite, phosphinite, phosphonite, phosphoramidate, thiophene, tetrahydrofuran, N heterocyclic carbene, acetonitrile or benzonitrile. In some examples the leaving group L may be linked covalently to the group
- to form a bidentate ligand. An example is given in the synthesis of a cis complex 65 described hereafter.
- The method may further comprise heating to convert trans complex (formula II) to cis complex (formula I). Thus the method can make complexes of formula II as well as those of formula I. Generally the method to prepare the complexes of the invention from the complex according to general formula VII from is carried out in a suitable solvent, typically a chlorinated solvent such as dichloromethane. Thermal conversion of a trans complex to a cis complex may be accomplished by heating in a suitable solvent such as, for example chloroform, toluene or nitromethane.
- Complexes of formulas VIII and IX may be made, for example by starting with a complex of formula I or formula II and displacing one of the coordinating ligands X. For example where X is halogen reaction with a silver salt of the anion Y− (e.g. AgSbF6) can produce the products of formula VIII, or X. The method is illustrated in
Scheme 3 below, where anionic ligand X is chloride in this example. Surprisingly reaction of an example complex of formula I where X is chloride with two equivalents of AgSbF6 did not produce a complex of formula IX, but rather a complex of formula X wherein one chloride was retained on the ruthenium, which was oxidised to the Ru III species shown. The method of preparing these cationic Ru complexes is another aspect of the present invention. - The complexes described herein can be used as catalysts.
- Thus according to a fourth aspect the present invention provides use of a complex according to general formula I:
- as a catalyst, wherein the groups A,X,Z, R1 and R2 have the same meaning as before.
- Complexes where Z is phosphite and A is an NHC have been shown to perform well in a range of catalytic duties as discussed hereafter and with reference to specific examples.
- Thus according to a fifth aspect the present invention provides use of a complex according to general formula II:
- as a catalyst, wherein the groups A,X,Z, R1 and R2 have the same meaning as before.
- Thus according to a yet further aspect the present invention provides use of a complex according to general formula VIII,IX or X:
- or a complex according to these formulas, wherein at least one vacant position about the metal centre is occupied by a neutral ligand, as a catalyst.
- Notably the trans complexes of formula II can show good catalytic activity at room temperature but the cis form (formula I) generally requires higher temperatures, suggesting that the cis form is a latent catalyst. Thus the trans form may be preferred in low temperature situations but as shown below at even moderate temperatures high conversion rates can be obtained when using the cis form. Furthermore the cis forms of the complexes are robust at elevated temperature, showing reduced tendency to loss of activity with time.
- The complexes may be used to catalyse a reaction selected from the group consisting of, for example, ring closing metathesis (RCM), enyne ring closing metathesis (enyne RCM), cross metathesis (CM) and ring opening polymerisation metathesis (ROMP). Results obtained are discussed hereafter and with reference to specific examples.
- Where the complexes described herein are employed for ROMP catalysis those that behave as latent catalysts may be used advantageously. Their latent catalyst behaviour, i.e. performing as catalysts when the temperature is elevated, allows particularly convenient processing when, for example, polydicyclopentadiene products are prepared from dicyclopentadiene.
- ROMP products are generally prepared by Reaction Injection Moulding (RIM) where the monomer, catalyst and any other components are injected into a mould under high pressure. On reaction a solid, moulded, product is prepared.
- In order to prevent uncontrolled or premature polymerisation previous catalyst systems for ROMP, in particular for polydicyclopentadiene (PDCPD) production have generally been provided as a two part system, with each part being dissolved or dispersed in a separate lot of monomer. The two monomer lots are then carefully mixed on injection into the mould where reaction occurs as the catalyst system is completed.
- With catalysts of the present invention showing latent behaviour, the monomer and any other components can be loaded into a mould (under pressure if required), with the catalyst already dissolved or dispersed within the monomer etc if desired. A small quantity of a suitable solvent, for example a chlorinated solvent such as dichloromethane may be employed to provide a solution of the catalyst.
- Reaction can then be initiated in a controlled fashion by heating to an appropriate temperature as described hereafter with reference to specific embodiments. Typically temperatures in the
range 30° C. to 120° C. or even 40° C. to 100° C. may be utilised. These relatively low reaction temperatures are convenient as monomers such as dicyclopentadiene have low boiling points - Alternatively, where a catalyst is selected that initiates reaction at lower temperatures, a procedure including mixing the catalyst into the monomer mixture as it is introduced into a mould may be used.
- Furthermore remarkably low catalyst loadings, of the order of 1 to 100 ppm in relation to monomer or even 5 to 60 ppm may be successfully employed in ROMP procedures making use of complexes of the invention as catalysts.
- In general ROMP using catalysts of the invention may be performed using as monomer any of the ring systems already known to undergo such processes.
- Suitable monomers for use in ROMP with the catalysts can include dicyclopentadiene, norbornene, norbornadiene, cyclooctadiene and derivatives, such as substituted derivatives of these monomers, thereof. Mixtures of monomers may also be employed and/or other components such as reinforcing fibres and fillers as known to those skilled in the art.
- Complexes of the invention wherein an NHC carbene is provided as group A and a phosphite is provided as group Z have been shown to be suitable for use in ROMP polymerisation. The NHC carbene may be selected from those described herein above, for example it may be one of:
- Complexes where the NHC is SIPr and A is a phosphite have been shown to perform well in ROMP procedures, in particular where A is tri-isopropyl phosphite as described hereafter and with reference to a particular example of a trans complex showing latent catalyst behaviour.
- Further features and advantages of the present invention will appear from the following detailed description of some embodiments illustrated with reference to the accompanying drawings in which:
-
FIGS. 1a to 1d show X-ray structures of complexes of the invention; -
FIG. 2 shows graphically trans to cis isomerisation of complexes of the invention; -
FIG. 3 shows graphically trans to cis isomerisation of complexes of the invention; and -
FIG. 4 shows graphically results of ring closure metathesis experiments using various catalysts. - Preparation of complexes of formulas I and II including an NHC
- A general procedure is to react complex 1 of
scheme 2 above with different groups Z, phosphites in these examples. Phosphites (1-4 equiv) in dichloromethane were reacted with 1 and stirred for 3-15 h at 60° C. This procedure led, whatever the phosphite employed was, to a mixture of two new complexes, presenting 31P NMR shifts corresponding to coordinated phosphites—between 110 and 135 ppm whereas free phosphites are around 128-145 ppm. - Where the phosphite ligand was P(OiPr)3, as shown in
Scheme 2 the conditions described above allow a 90% pure complex (31P NMR in CDCl3, major: δ=113 ppm, minor: δ=123 ppm), to be isolated as a red powder. NMR experiments in d8-toluene showed that, after 1 h at 80° C., the complex presenting a chemical shift at 113 ppm was highly converted into the one at 123 ppm. The latter complex was thus isolated and characterized. - 1H NMR of the two complexes showed interesting differences on the phosphite alkoxy groups. Indeed, nicely resolved doublets corresponding to the six equivalent terminal methyl groups of the isopropyl groups in the first complex were found inequivalent in the latter complex, indicating that the free rotation of the phosphite was no longer possible. In addition, 13C NMR experiments were conducted to observe, in both complexes, the J coupling between the NHC carbenic carbon and the phosphite phosphorus. While the firstly generated complex (31P, δ=113 ppm) displayed a carbenic carbon at 208.9 ppm with a classical coupling constant JC-P=124 Hz, the second complex (31P, δ=127 ppm) displayed an unusual small coupling of 13 Hz. These observations led to the conclusion that complex trans-2, featuring a trans configuration between the NHC and the phosphite, was obtained kinetically while cis-2 was thermodynamically favored (scheme 2). Complex cis-2 could also be isolated on a larger scale in a good yield of 86% by heating trans-2 in chloroform at 60° C. for 5 h. Interestingly, aspect and solubility were completely different for trans-2 and cis-2. Indeed, while trans-2 was isolated as a red powder that is soluble in polar and apolar solvents, cis-2 is a black solid completely insoluble in pentane, indicating a dependence of physical properties to spatial arrangement. The structure of cis-2 has been confirmed by X-ray crystallography, following growth of a suitable crystal from CH2Cl2/n-dodecane. (See
FIG. 1b ). The X-ray data also show that the complex cis-2 is present as a pair of enantiomers as discussed above. - In order to obtain cis-complexes directly, with different phosphite ligands, 1 and a selected phosphite were stirred at 40° C. in dichloromethane for the appropriate time (Table 1, below). Following the reaction by 1H and 31P NMR furnished showed different conversion rates. As a general trend, reactivity was dependent on the cone angle of the phosphite. Indeed, the reaction was found to be slower with bulky phosphites such as P(OiPr)3 and P(OPh)3, (15 h), while smaller phosphites such as P(OMe)3 required only 3 h at 40° C. For P(OPh)3, 4 equiv of P(OPh)3 were necessary to obtain relatively fast conversion to the desired complex. With these conditions, complexes cis-2-5 (Table 1) were isolated in yields up to 88%, For cis-3 the lower yield was due to purification difficulties. X ray structures of cis-4, cis-2, cis-3 and cis-5 are shown in
FIGS. 1a to 1d respectively. -
TABLE 1 Synthesis of cis-Ru-Phosphite complexesa [Ru] Yield Entry P(OR)3 (equiv) θ (°)b complex Time (%) 1 P(OMe)3 (1) 107 cis-3 3 h 57 2 P(OEt)3 (1) 109 cis-4 5 h 88 3 P(OiPr)3 (1) 128 cis-2 15 h 84 4 P(OPh)3 (4) 130 cis-5 15 h 76 aReaction conditions: 1 (1 equiv), phosphite, CH2Cl2, 40° C. bTolman cone angle. NMR studies in CD3NO2 and toluene-d8 (FIGS. 2 and 3 respectively) show the thermal conversion from trans to cis of a sample that contained 90% trans: 10% cis complex 2. - All the experiments shown were followed by NMR starting from the trans-2 complex complex (pure at 90%, with 10% of cis isomer), except in toluene one experiment at 50° C. started from the pure cis-2. As we can see, polar solvents (nitromethane) favored the formation of the cis isomer whereas apolar solvent (toluene) reached an equilibrium cis/trans 80:20. It seems that a temperature of 30° C. is too low to allow fast conversion. Starting from the cis isomer and heating in toluene led also to a mixture cis/trans 80:20. The first set of curves allowed the calculation of ΔH=22.6 kcal/mol and ΔS=−4.2 cal/mol.
- A further example of a synthesis producing an NHC containing cis complex is shown below.
- HII (200 mg) and P(OiPr)3 (5 eq) were stirred in for 72 h. The crude 65 was recrystallised from DCM/pentane.
- 1H (400 MHz, 298K): 16.05 (d, 1H, J=35.3 Hz, C═CH), 10.24 (d, 1H, J=9.7 Hz, Ph-H), 6.87-6.83 (m, 2H, Ph-H), 6.78 (s, 1H, Ph-H), 6.61 (s, 1H, Ph-H), 6.19-6.16 (m, 2H, Ph-H), 4.67 (brs, 2H, PO—CH—CH3), 4.09-4.06 (m, 1H, Ph-O—CH—CH3), 4.04 (brs, 1H, PO—CH—CH3), 3.43-3.40 (m, 1H), 3.16-3.02 (m, 3H), 2.89 (s, 3H, Mes-CH3), 2.58 (s, 3H, CH3), 2.46 (s, 3H, CH3), 2.42 (s, 3H, CH3), 2.18 (s, 3H, CH3), 1.92 (s, 3H, CH3), 1.48-0.80 (m, 24H, PO—CH—CH3). 31P{1H} (121.49 MHz, 298K): 128.7 (s)
- Catalytic activity of complexes was evaluated in ring closing metathesis (RCM), enyne ring closing metathesis (enyne RCM) and cross metathesis (CM). The difference of behavior between trans-2 and cis-2 was studied. The main difference appeared when reactions were run at room temperature. Indeed, whereas trans-2 was able to achieve RCM of
diallyltosylamine 6, albeit with lower activities compared to previously reported indenylidene ruthenium complexes, cis-2 was found to be totally inactive at room temperature, even after 24 hours of reaction (Table 2, below, entry 1). Nevertheless, with the same substrate, thermal activation at 80° C. in toluene allowed fast conversion in the presence of cis-2. The same trend was observed in RCM withdiallyllic malonate 8, in enyne RCM with 10 and CM with alkene 12 (Table 2, entries 2-4), trans-2 being active at rt while cis-2 needed thermal activation. Such behavior corresponds to a latent catalyst. In order to evaluate the thermal stimulation needed to activate cis-2, RCM of 6 was monitored at different temperatures (25, 40, 60 and 80° C.), the temperature being changed every 30 minutes. No conversion was observed at room temperature and 40° C., 4% conversion at 60° C., and full conversion at 80° C. As a consequence, the comparative study of complexes cis-2 to 5 was conducted at 80° C. - In Table 2 below results for known complexes M2 (scheme 1) and 1 (pyridine containing complex of scheme 2) are also shown for comparison purposes.
-
TABLE 2 Behaviour of trans-2 vs cis-2.a catalyst T t conv. Entry Substrate Product [mol %] [° C.] [h] [%]b 1 trans-2 (1) cis-2 (1) rt rt 40 60 805 24 24 0.5 0.5 0.5 18 88 9 9 4 >99 2 1 (1) M2 (1) trans-2 (1) cis-2 (1) rt rt rt rt 805 5 5 24 0.5 38 82 80 0 >99 3 1 (1) M2 (1) trans-2 (1) cis-2 (1) rt rt rt rt 8024 24 24 24 0.5 12 63 52 0 >99 4 trans-2 (2) cos-2 (2) cis-2 (2) rt rt 808 8 0.5 1.75 65 0 90 97 aReaction conditions: substrate (0.25 mmol), catalyst (1-2 mol %), solvent (0.1 M, CH2Cl2 and toluene for reactions respectively at room temperature and 80° C.). bAverage of 2 runs; conversions were determined by 1H NMR. - Complexes were studied as catalysts in RCM of diene, enyne and in CM (Table 3 below). Known complexes 1 (pyridine containing complex of
scheme 2, known as M31), M1 and M2 (scheme 1) were also included in some experiments for comparison purposes. - These complexes are available from Umicore N.V.;
Broekstraat 31 rue du Marais B-1000 Brussels, Belgium. - A general trend was found between reactivity and the phosphite substituent for the new complexes. Triisopropyl phosphite and triphenyl phosphite-containing complexes cis-2 and 5 were found to have comparable efficiency, the former one being slightly more active. Indeed, after 30 minutes, RCM of 8 was achieved with cis-2 while traces of 8 could still be detected with cis-5. Even clearer evidences were provided with reactions of 10 and 12, cis-2 being faster than cis-5. Finally, cis-3 and 4, featuring respectively trimethyl and triethylphosphite were similar but far less reactive than cis-2 and 5. Very slow reactivity was observed in the reactions tested, even if a longer reaction time could probably reach full conversion. In order to explore the applicability of such catalysts in metathesis transformations, we chose to run reactions with catalyst cis-2 and at elevated temperature.
-
TABLE 3 Behaviour of cis-2-5.a catalyst T t conv. Entry Substrate Product [mol %] [° C.] [h] [%]b 1 cis-2 (1) cis-3 (1) cis-4 (1) cis-5 (1) 1 (0.5) M1 (0.5) M2 (0.5) trans-2 (0.5) 80 80 80 80 80 80 80 80 0.5 0.5 1 0.5 1 0.5 1 0.5 0.5 0.5 0.5 >99 78 >99 35 73 98 >99 >99 >99 >99 >99 2 cis-2 (0.5) cis-3 (0.5) cis-4 (0.5) 80 80 80 80 0.5 1.75 1.75 1.75 1.75 72 >99 5 10 91 3 cis-2 (2) cis-3 (2) cis-4 (2) cis-5 (2) 80 80 80 80 0.5 1.75 0.5 1.75 0.5 1.75 0.5 1.75 90 97 6 38 13 67 60 94 aReaction conditions: substrate (0.25 mmol), catalyst (0.5 to 2 mol %), toluene (0.1 M), 80° C. bConversions were determined by 1H NMR. - A study of the RCM of several substrates has also been carried out. Reactions were run in toluene at 80° C. in the presence of 1 to 5 mol % of cis-2, the higher catalyst loading being only necessary for the formation 17 featuring a tetra-substituted double bond (Table 4 below, entry 3). The RCM of unhindered malonate derivatives was achieved in short reaction times (less than 1 hour) and in good yields. Indeed, di- and tri-substituted cyclopentenes 15 and 9 were obtained in quantitative yields (
entries 1 & 2). Nevertheless, highly constrainedsubstrate 16 could not be cyclized with full conversion, even after 24 h at 80° C., and was isolated in 70% yield (entry 3). Finally, 6- and 7-membered rings 19 and 21 were obtained in respectively 96 and 87% yield, and no increase in reaction time compared to 5-membered ring 15 (entries 4 & 5). Of note, a dilution to 0.05M was necessary to obtain 21 without observing parallel formation of polymers. We next attempted the RCM of cyano analogues 24 and 26 (entries 6 & 7). Non-hindered cyclopentene 23 was isolated in good yield (88%), indicating that the presence of potentially chelating cyano groups was not detrimental to catalysis. Nevertheless, cis-2 was unable to promote the formation of 25, the starting material remaining unreacted. Tosylamine-based olefins were next investigated. The cyclization of these compounds was found very efficient regardless of hindrance and ring size. Indeed, 5-, 6- and 7-membered compounds 7, 27 and 29 were isolated in excellent yields (entries 8-10), albeit a slight increase in reaction time was needed for larger rings. Catalyst loading of only 2 mol % was necessary to achieve the cyclizations of 30 and 32 to obtain tetrasubstituted 5- and 6-membered rings 31 and 33 in good yields (entries 11 & 12), even so 5 hours of reaction were needed fordihydropyrrole 31. Amide and ether-based substrates were also efficiently cyclized, with yields spanning from 80% to 99% (entries 13-17). Increasing the ring size to 6 or 7 members was not detrimental, as products 39, 41 and 43 were obtained excellent yields in less than 1 hour (entries 15-17). From this study, catalyst cis-2 seemed to be highly tolerant to functionalities and able to effect RCM easily. - This utility of the complexes of the invention is illustrated further in
FIG. 4 which shows RCM of compound 30 (table 4 entry 11) in toluene at 80° C. carried out with a range of Ru complexes. Trans or cis-2 both rapidly produce a high conversion whereas prior art complexes Hov-II, G-II, M2 (structures shown in Scheme 1) and M31 (which is thepyridine complex 1 in scheme 2) did not produce any better than about 60% conversion (complex M2) under these conditions. -
TABLE 4 Ring closing metathesis behavior of cis-2a t conv. Entry Substrate Product [h] [%]b 1 0.5 >99 (99) 2 0.5 >99 (99) 3c 24 82 (70) 4 0.5 >99 (96) 5d 1 >99 (87) 6 0.5 >99 (88) 7c 24 0 8 0.5 >99 (97) 9 1.25 >99 (99) 10 1 >99 (88) 11e 5 >99 (95) 12e 1.5 >99 (99) 13 0.5 >99 (99) 14 0.75 >99 (80) 15 0.75 >99 (99) 16 0.5 >99 (94) 17d 0.75 >99 (99) aReaction conditions: substrate (0.25 mmol), cis-2 (1 mol %), toluene (0.1 M), 80° C. bAverage of 2 runs; conversions were determined by NMR; isolated yields are in brackets. c5 mol % of catalyst were used. d0.05 M concentration was used. e2 mol % of catalyst were used. - Enyne ring closing metathesis is a powerful tool to synthesize dienes that can undergo further Diels-Alder reaction and thus furnish bicyclic compounds readily.
Easy substrates 10 and 44 were fully converted after 30 minutes, albeit 11 was only isolated in 75% yield (Table 5 below,entries 1 & 2). A longer reaction time was necessary to convert hindered compound 46 (entry 3). Once again, a relatively low isolated yield of 71% (compared to 99% conversion) was obtained; such behaviour could result from parallel polymerisation reactions that can easily occur at elevated temperature. While substrate 48 remained unchanged after 24 h of reaction, the more hinderedenyne 50 was efficiently cyclized in 3 h (entries 4 & 5). Addition of ethylene is known to be necessary to allow reaction in the case of terminal alkynes such as 48. In conclusion, catalyst cis-2 allowed the formation of dienes from enynes in a short reaction time and acceptable yields. -
TABLE 5 Enyne ring closing metathesis behaviour of cis-2a En- t conv. try Substrate Product [h] [%]b 1 0.5 >99 (75) 2 0.5 >99 (99) 3c 19 >99 (71) 4 24 0 5 3 >99 (81) aReaction conditions: substrate (0.25 mmol), cis-2 (1 mol %), toluene (0.1 M), 80° C. bAverage of 2 runs; conversions were determined by NMR; isolated yields are in brackets. c5 mol % of catalyst were used. - The ability of catalyst cis-2 to promote intermolecular cross metathesis has also been investigated (Table 6 below). CM reactions are more difficult than their RCM counterparts as side-formation of self-metathesis products may happen. Several substrates were put in presence of 2 mol % of cis-2, together with 2 equivalents of alkene partners in toluene at 80°
C. Silylated compound 12 was efficiently coupled with various olefins (entries 1-4). Indeed, the use of methyl acrylate, acrolein and diallylic acetate as alkene partners allowed the isolation of the desired products, respectively 13, 52 and 54, in good yields compared to previously reported results, thus proving that cis-2 has a good tolerance toward functional groups (entries entries 5 & 6). Both products were isolated as E isomers, the Z ones not being detected by 1H NMR. Reaction of eugenol 59 (essential oil of clove) with acrolein was found efficient and did not need protection of its phenolic moiety (entry 7). Finally, p-chlorostyrene 61 reacted well with methyl acrylate and gave 62 in 81% yield with an E/Z ratio of 20:1. No formation of self-metathesis compounds was observed during the testing of these substrates. -
TABLE 6 Cross metathesis behaviour of cis-2a Alkene t Yield Entry Substrate partner Product [h] [%] (E/Z)b 1 2 81 (>20:1) 2 2 57 (>20:1) 3 3.5 0 4c 3.5 59 (6:1) 5 2.5 85 (>20:1) 6 2.5 75 (>20:1) 7 5 62 (6:1) 8 3 81 (>20:1) aReaction conditions: substrate (0.25 mmol), alkene partner (0.5 mmol), cis-2 (2 mol %), toluene (0.1 M), 80° C. bAverage of 2 runs; isolated yields; E/Z ratios were determined by 1H NMR. cOnly 1 equiv of alkene partner was used. -
- The complex cis-2 was reacted at room temperature with one equivalent of silver hexafluoroantimonate, yielding the pure complex 63, after simple removal of salts by filtration on celite.
- 13C{1H} NMR spectrum of 63 displayed a coupling constant between the carbene carbon atom and the phosphite ligand 2JC-P of 15.1 Hz, consistent with a cis-configuration between the NHC and the phosphite ligands. This value is very similar to the one found for cis-2 (13.4 Hz) and very far from the one found for trans-2 (127.8 Hz). Similarly, the 2JC-P between the indenylidene carbon atom C1 and the phosphorus atom of 63 (23.2 Hz) was also found very similar with the 24.7 Hz obtained with cis-2 (trans-2 31.0 Hz).
- The structure of 63 was confirmed by X-ray crystallography.
- Complex 63 may be converted into an acetonitrile containing species 63a as below:
- In a glove box, 63 (77.0 mg, 0.071 mmol) was dissolved in 1 mL of acetonitrile and the mixture was stirred for fifteen minutes. Solvent was removed in vacuo. The black solid was washed with hexane yielding 63a (99%).
- 1H NMR (CD2Cl2, 400 MHz): δ (ppm)=1.13 (d, 3JHH=5.6 Hz, 9H, CH—CH3), 1.17 (d, 3JHH=5.6 Hz, 9H, CH—CH3), 2.02 (s, 6H, mesityl CH3), 2.06 (s, 3H, CH3), 2.16 (s, 6H, mesityl CH3), 2.34 (s, 6H, mesityl CH3), 4.01 (s, 4H, carbene CH2), 4.31 (s br, 3H, CH—CH3), 6.32 (s, 1H, indenylidene H), 6.74 (s, 2H, mesityl CH), 6.87 (s, 2H, mesityl CH), 7.32 (d, 3JHH=8.0 Hz, 1H, indenylidene H), 7.41-7.50 (m, 4H, indenylidene), 7.59 (t br, 3JHH=7.3 Hz, 1H, indenylidene H), 7.63 (d br, 3JHH=7.3 Hz, 2H, indenylidene H), 7.83 (s, 1H, indenylidene H).
- 31P{1H} NMR (CD2Cl2, 162 MHz) δ (ppm)=115.5
- The catalytic potential of 63 was first assessed for the RCM (ring closing metathesis) of the challenging tosylamine derivative 30 (Table 7) at a low catalyst loading (0.1 mol % Ru).
- At 80° C., all solvents gave no or very poor conversions (Table 7, entries 1-3). Reactions carried out in xylene or mesitylene at temperatures above 110° C. (120-140° C.) gave
product 31 with good conversions (76-79%) (Table 7,entries entries 6, 8). -
TABLE 7 Optimization of reaction conditions. Entry Solvent T [° C.] Conv. [%]b 1 toluene 80 7 2 acetonitrile 80 0 3 iso- propanol 80 1 4 xylene 120 76 5 xylene 130 77 6 dimethyl sulfoxide 140 0 7 neat 140 60 8 1,2- 140 50 dichlorobenzene 9 mesitylene 140 77 10 xylene 140 79 11 mesitylene 160 69 [a]Reaction conditions: 30 (0.25 mmol), 63 (0.1 mol % Ru), solvent (1 mL), 3 h. [b]Average of 2 runs; conversions determined by GC. - Under the optimized reaction conditions (
entry 10 of Table 7), the kinetic profile of 63 was recorded and compared to that of its parent neutral complex cis-2 (FIG. 5 ). At 140° C., cis-2 exhibits a very fast initiation and a high activity for only 3 minutes. Decomposition of the cis-2 occurred rapidly and the catalyst could not achieve more than 60% of conversion. Better results were obtained in table 4 (entry 11 above) where more catalyst and a longer reaction time was employed. In contrast, a thermal treatment of 3 minutes at 140° C. was found necessary to activate 63 indicating it can be considered a latent catalyst, which then achieved 80% conversion within 10 minutes. This shows that 63 is more thermally stable than cis-2. - The catalytic potential of 63 was than investigated for a range of dienes and enynes, under these harsh reaction conditions: 140° C., 15 min (Table 8).
-
TABLE 8 Metathesis reactions behavior of 63. Conversion (isolated Entry Substrate product Cat (mol. %) yield)[b] 1 0.1 99 (90) 2 0.1 99 (97) 3 0.1 91 (85) 4 0.2 90 (89) 5 0.2 99 (96) 6 0.1 99 (92) 7 0.1 99 (95) 8 2 51 9 10 0.2 99 (79) 10 64 (1 eq.) 66 (2 eq.) 0.4 81 (72) [a]Reaction conditions: 63 (0.1-2 mol %), substrate (0.25 mmol), xylene (1 mL), 15 min, 140° C. [b]Average of 2 runs; conversions determined by GC; selected isolated yields in brackets. -
- R=2,4,6-Me3C6H2
- In a glove box, Ru complex cis-2 (0.150 g, 0.171 mmol) and silver hexafluoroantimonate (0.130 g, 0.366 mmol) and dichloromethane (5 mL) were charged in a dry flask. The reaction mixture was stirred for fifteen minutes and the solution was filtered through a plug of celite. After evaporation of solvent, pentane was added and the precipitate was collected by filtration and washed with pentane. 67 was obtained as a black greenish solid in 95% (0.1990 mg). The structure of 67 was ultimately determined by X-ray crystallography, demonstrating that a chloride had been retained and the Ru had therefore been oxidized to the III state, presumably by Ag(I) being reduced to Ag(0).
- A cis complex 68 comprising a phosphine and a phosphite as ligands A and Z can be made as follows:
- Under an inert atmosphere, triisopropylphosphite (364 μL, 1.53 mmol) was added to a solution of M1 (1.4145 g, 1.53 mmol), in dichloromethane (20 mL). The mixture was stirred for 24 h at room temperature, then the solvent was removed in vacuo. The crude was recrystallised from CH2Cl2/pentane. The solid was collected by filtration and washed with pentane (3×10, 2×15 mL). The product 68 was obtained as a brownish red solid (1.116 g, 85% yield).
- 1H-NMR (400 MHz, 298K): δ (ppm)=1.10-1.35 (m, 27H), 1.40-1.55 (m, 6H), 1.60-1.85 (m, 14H), 6.79 (s, 1H, indenylidene H), 7.27 (d, J=7.1 Hz, 1H, indenylidene H), 7.43 (dd, J=6.7 Hz, J=6.3 Hz, 1H, indenylidene), 7.44 (dd, J=7.4 Hz, J=6.3 Hz, 2H, indenylidene), 7.50 (dd, J=7.4 Hz, J=7.7 Hz, 1H, indenylidene), 7.53 (dd, J=7.4 Hz, J=7.4 Hz, 1H, indenylidene), 7.76 (d, 3JHH=7.3 Hz, 2H, indenylidene), 8.80 (d, J=7.3 Hz, 1H, indenylidene). 31P-{_H}-NMR (162 MHz, 298K): δ (ppm) 120.1 (d, J=37.0 Hz), 47.4 (d, J=37.0 Hz).
- Following a similar procedure, with more phosphite reagent, the cis bis-phosphite complex 69 can be obtained.
- 31P-{1H}-NMR (CD2Cl2, 162 MHz): δ (ppm)=122.9.
- Complex 1 (also known as M31) of
scheme 2 was reacted with further phosphite ligands as shown below. - The cis complexes 70a to 70e feature various para substituents on the phenyl rings of the phosphite ligands. These variations in the phosphite ligand can be employed to adjust catalytic activity.
- The general procedure employed in manufacture was as follows:
- A Schlenk flask was charged with [RuCl2(Ind)(Py)(SIMes)] (M31) (0.5 g, 0.668 mmol), the corresponding phosphite (0.801 mmol, 1.2 eq) and dichloromethane (8 mL). The reaction was stirred at 40° C. during 15 hours, concentrated in vacuo and pentane was added. The precipitate was collected by filtration and washed with pentane.
- Using 500 mg of M31 (0.668 mmol), the procedure afforded 479 mg (67%) of the product.
- 1H NMR (CD2Cl2, 300 MHz, 233K): δ (ppm)=1.47 (s, 3H, CH3), 1.90 (s, 3H, CH3), 2.11 (s, 3H, CH3), 2.41 (s, 3H, CH3), 2.62 (s, 3H, CH3), 2.75 (s, 3H, CH3), 3.04 (s, 3H, O-Me), 3.65 (s, 3H, O-Me), 3.88 (s, 3H, O-Me), 3.68-4.02 (m, 4H), 5.62 (d, J=9.1 Hz, 2H), 6.05 (s, 1H), 6.10 (d, J=8.8 Hz, 2H), 6.18 (s, 2H), 6.39 (d, J=8.8 Hz, 2H), 6.57 (d, J=9.12 Hz, 2H), 6.93 (d, J=6.9 Hz, 2H), 7.08 (d, J=9.2 Hz, 3H), 7.22 (t, J=7.2 Hz, 1H), 7.33 (s, 1H), 7.26-7.39 (m, 4H), 7.42-7.49 (m, 3H), 8.61 (d, J=7.8 Hz, 1H).
- 31P-{1H} NMR (CD2Cl2, 162 MHz, 298K): δ (ppm)=116.1.
- Using 500 mg of M31 (0.668 mmol), the procedure afforded 479 mg (61%) of the product.
- 1H NMR (CD2Cl2, 300 MHz, 233K): δ (ppm)=1.50 (s, 3H, CH3), 1.95 (s, 3H, CH3), 2.09 (s, 3H, CH3), 2.42 (s, 3H, CH3), 2.60 (s, 3H, CH3), 2.73 (s, 3H, CH3), 3.72-4.05 (m, 4H), 6.00 (s, 1), 6.10 (s, 1H), 6.23 (s, 1H), 6.37 (d, J=8.25 Hz, 2H), 6.47 (d, J=8.25 Hz, 2H), 6.64 (d, J=8.25 Hz, 2H), 6.87 (d, J=7.18 Hz, 1H), 6.95 (s, 1H), 7.10 (s, 1H), 7.23 (m, 3H), 7.30 (d, J=7.45 Hz, 1H), 7.38 (m, 4H), 7.47 (m, 1H), 7.64 (d, J=8.52 Hz, 2H), 7.91 (d, J=8.52 Hz, 2H), 8.58 (d, J=7.22 Hz, 1H).
- 31P-{1H} NMR (CD2Cl2, 162 MHz, 298K): δ (ppm)=114.2.
- Using 500 mg of M31 (0.668 mmol), the procedure afforded 496 mg (66%) of the product. 31P-{1H} NMR (CD2Cl2, 162 MHz, 298K): δ (ppm)=115.9.
- Using 500 mg of M31 (0.668 mmol), the procedure afforded 242 mg (33%) of the product. 31P-{1H} NMR (CD2Cl2, 162 MHz, 298K): δ (ppm)=115.3.
- Using 500 mg of M31 (0.668 mmol), the procedure afforded 860 mg (95%) of the product.
- 31P-{1H} NMR (CD2Cl2, 162 MHz, 298K): δ (ppm)=114.4.
- As an alternative to adjusting the phosphorus containing ligand the NHC ligand may be altered to amend catalyst behaviour. For example providing bulkier ligands on the NHC can promote higher catalytic activity. For example the provision of bulkier alkyl substituents on the aromatic rings of imidazole based NHC ligands can impart improved catalyst behaviour.
- The provision of isopropyl groups rather than the methyl groups of complexes such as for
example complexes 70 discussed above has been shown to improve catalyst activity, in particular in ROMP polymerisation, using the polymerisation of dicyclopentadiene as an example. - Thus complex 72 prepared as shown below from the known pyridine containing complex 71 performs well in ROMP experiments. Complex 72 is prepared in a trans form as shown below, but it has been shown to behave as a latent catalyst, in particular in ROMP reactions.
- Inside a glovebox a solution of 71 [RuCl2(SIPr)Py(Ind)] (500 mg, 0.60 mmol) in toluene (5 mL) was treated with triisopropyl phosphite (163 μL, 0.66 mmol). The reaction mixture was stirred at room temperature (for 6 h) and the solvents removed under vacuum. The resulting solid was washed affording 72 as an orange solid (460 mg, 0.48 mmol, 80%).
- 1H NMR (CD2Cl2, 400 MHz): =8.78 (d, J=7.3 Hz, 1H), 7.57 (d, J=7.3 Hz, 2H), 7.46-7.53 (m, 1H), 7.32-7.45 (m, 5H), 7.20-7.28 (m, 1H), 7.10-7.17 (m, 1H), 7.01 (d, J=7.2 Hz, 1H), 6.71-6.77 (m, 1H), 6.58-6.69 (m, 2H), 6.28 (s, 1H), 4.41-4.53 (m, 1H), 4.07-4.21 (m, 1H), 3.90-4.06 (m, 2H), 3.61-3.88 (m, 6H), 3.00 (sept, J=6.7 Hz, 1H), 1.63 (2 d, J=6.7 Hz, 6H), 1.54 (d, J=6.3 Hz, 3H), 1.26 (d, J=6.7 Hz, 3H), 1.22 (t, J=6.3 Hz, 6H), 0.95 (d, J=6.0 Hz, 9H), 0.84-0.84 (m, 1H), 0.86 (d, J=6.8 Hz, 3H), 0.74 (d, J=6.0 Hz, 9H), 0.44 ppm (d, J=6.7 Hz, 3H)31P NMR (CD2Cl2, 121 MHz, CD2Cl2) 116.65 ppm. 13C NMR (CD2Cl2, 101 MHz) =300.8, 217.3, 150.3, 149.9, 148.3, 147.6, 146.8, 143.5, 143.4, 141.3, 140.8, 137.7, 136.9, 136.8, 136.0, 131.6, 131.5, 130.2, 130.1, 129.5, 129.3, 128.9, 128.2, 127.1, 126.7, 125.6, 125.3, 124.7, 124.0, 117.0, 69.8, 69.2, 69.2, 55.3, 55.2, 55.1, 54.4, 54.3, 54.1, 53.6, 53.3, 30.2, 29.5, 29.3, 28.8, 27.3, 27.2, 27.1, 26.8, 25.6, 24.9, 24.4, 24.3, 24.3, 24.1, 23.8, 23.7, 23.7, 23.6, 28.0, 21.9 ppm Anal. Calcd for C51H69Cl2N2O3PRu (MW 961.05): C, 63.74; H, 5.75; N, 4.61. Found: C, 63.73; H, 7.46; N, 3.02.
- Experiments were carried out using complexes of the general form:
- where the required amount of catalyst was dissolved in dichloromethane (600 microlitres) and added to dicyclopentadiene (dcpd −10 mL). The mixture was stirred, poured into the mould and heated to the required temperature to provide polydicyclopentadiene (PDCPD).
- Substantial polymerisation did not occur at room temperature, showing the latency of the catalyst. However, the mixtures can form a gel at room temperature indicating some initiation of polymerisation. Heating at temperatures between 40 and 100° C. was required to provide full polymerisation. Thus a smooth controlled polymerisation could be carried out, without e.g. boiling off of the monomer due to an exotherm.
- The amount of catalyst used varied between 5 to 60 ppm, based on amount of monomer.
- For example, where complex 72 was employed, polymer products having a good aspect (a hard product, conforming to the mould shape) were formed. The polymers also showed good transparency and low odour. These results indicate that high conversion of monomer can be obtained. Additives such as graphite, silica or celite were added in some experiments to make a composite material.
- Other complexes, including cis complexes such cis-2 described before also provided polydicyclopentadiene by the procedure described above.
-
- 1. a) Nguyen, S. T.; Johnson, L. K.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1992, 114, 3974-3975. (b) Schwab, P; France, M. B.; Ziller, J. W.; Grubbs, R. H. Angew. Chem. 1995, 107, 2179-2181; Angew. Chem., Int. Ed. Engl. 1995, 34, 2039-2041.
- 2. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-956.
- 3. (a) Kingsbury, J. S.; Harrity, J. P. A.; Bonitatebus, P. J.; Hoveyda, A. H. J. Am. Chem. Soc. 1999, 121, 791-799. (b) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168-8179.
- 4. (a) Grela, K.; Harutyunyan, S.; Michrowska, A. Angew. Chem. 2002, 114, 4210-4212; Angew. Chem., Int. Ed. 2002, 41, 4038-4040. (b) Wakamatsu, H.; Blechert, S. Angew. Chem. 2002, 114, 2509-2511; Angew. Chem., Int. Ed. 2002, 41, 2403-2405. (c) Zaja, M.; Connon, J.; Dunne, A. M.; Rivard, M.; Buschmann, N.; Jiricek, J.; Blechert, S. Tetrahedron 2003, 59, 6545-6558. (d) Michrowska, A.; Bujok, R.; Harutyunyan, S.; Sashuk, V.; Dolgonos, G.; Grela, K. J. Am.
- Chem. Soc. 2004, 126, 9318-9324.
- 5. For a review on ruthenium indenylidene complexes, see: Dragutan, V.; Dragutan, I.; Verpoort, F. Platinum Met. Rev. 2005, 49, 33-40. See also for increased stability of such complexes: Clavier, H.; Petersen, J. L.; Nolan, S. P. J. Organomet. Chem. 2006, 691, 5444-5477, and references therein.
- 6. (a) Jafarpour, L.; Schanz, H.-J.; Stevens, E. D.; Nolan, S. P.
Organometallics 1999, 18, 5416-5419. (b) Clavier, H.; Nolan, S. P. Chem. Eur. J. 2007, 13, 8029-8036. (c) Boeda, F.; Bantreil, X.; Clavier, H.; Nolan, S. P. Adv. Synth. Catal. 2008, 350, 2959-2966. (d) Clavier, H.; Urbina-Blanco, C. A.; Nolan, S. P. Organometallics 2009, 28, 2848-2854. - 7. a) A. Furstner, M. Picquet, C. Bruneau, P. H. Dixneuf, Chem. Commun. 1998, 2249-2250; b) M. Picquet, C. Bruneau, P. H. Dixneuf, Chem. Commun. 1998, 1315-1316; c) A. Furstner, M. Liebl, C. W. Lehmann, M. Picquet, R. Kunz, C. Bruneau, D. Touchard, P. H. Dixneuf, Chem. Eur. J. 2000, 6, 1847-1857.
- 8. a) S. M. Hansen, M. A. O. Volland, F. Rominger, F. Eisenträger, P. Hofmann, Angew. Chem., Int. Ed. 1999, 38, 1273-1276; b) P. Hofmann, M. A. O. Volland, S. M. Hansen, F. Eisenträger, J. H. Gross, K. Stengel, J. Organomet. Chem. 2000, 606, 88-92; c) M. A. O. Volland, S. M. Hansen, F. Rominger, P. Hofmann, Organomet. 2004, 23, 800-816.
- 9. a) Y. Miyaki, T. Onishi, H. Kurosawa, Inorg. Chim. Acta 2000, 369-377; b) Y. Miyaki, T. Onishi, S. Ogoshi, H. Kurosawa, J. Organomet. Chem. 2000, 616, 135-139.
- 10. D. Wang, K. Wurst, W. Knolle, U. Decker, L. Prager, S. Naumov, M. R. Buchmeiser, Angew. Chem., Int. Ed. 2008, 47, 3267-3270.
- 11. P. E. Romero, W. E. Piers, J. Am. Chem. Soc., 2005, 127, 5032-5033; P. E. Romero, W. E. Piers, R. McDonald, Angew. Chem. Int. Ed., 2004, 43, 6161-6165.
- 12. C. Slugovc, B. Perner, F. Stelzer, K Mereiter, Organometallics, 2004, 23, 3622-3626.
- 13. a) T. Ung, A. Heijl, R. H. Grubbs, Y. Schrodi, Organometallics, 2004, 23, 5399-5401; b) M. Barbasiewicz, A. Szadkowska, R. Bujok, K. Grela, Organometallics, 2006, 25, 3599-3604; c) X. Gstrein, D. Burtscher, A. Szadkowska, M. Barbasiewicz, F. Steltzer, K. Grela, C. Slugovc, J. Polym. Sci., Part A: Polym. Chem., 2007, 45, 3494-3500; d) A. Ben-Asuly, E. Tzur, C. E. Diesendruck, M. Sigalov, I. Goldberg, N. G. Lemcoff, Organometallics, 2008, 27, 811-813; e) C. E. Diesendruck, V. Vidavsky, A. Ben-Asuly, N. G. Lemcoff, J. Polym. Sci., Part A: Polym. Chem., 2009, 47, 4209-4213; f) C. E. Diesendruck, E. Tzur, A. Ben-Asuly, I. Goldberg, B. F. Straub, N. G. Lemcoff, Inorg. Chem., 2009, 48, 10819-10825; g) A. Ben-Asuly, A. Aharoni, C. E. Diesendruck, Y. Vidavsky, I. Goldberg, B. F. Straub, N. G. Lemcoff, Organometallics, 2009, 28, 4652-4655; h) E. Tzur, A. Szadkowska, A. Ben-Asuly, A. Makal, I. Goldberg, K. Wozniak, K Grela, N. G. Lemcoff, Chem. Eur. J., 2010, 16, 8726-8737.
- 14. M. Zirngast, E. Pump, A. Leitgeb, J. H. Albering, C. Slugovc, Chem. Commun., 2011, 47, 2261-2263.
Claims (25)
1. A method of catalyzing a metathesis reaction comprising:
contacting a monomer comprising at least one olefin and/or alkyne functional group with a trans ruthenium complex according to formula II:
wherein for each occurrence the groups X are the same or different and are anionic ligands or are fused to form a bidentate ligand;
the groups R1 and R2 are the same or different and are selected from the group consisting of hydrogen, C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, C2-C20 alkoxycarbonyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C1-C20 alkylthio, C1-C20 alkylsulfonyl, and C1-C20 alkylsulfinyl; and when not hydrogen are optionally substituted; or
the groups R1 and R2 are fused together to form a ring that may be substituted or unsubstituted, saturated or unsaturated and may be fused to a further ring; and
the group Z is selected from the group consisting of:
wherein the groups R3, R4 and R5 are each independently for each occurrence selected from the group consisting of substituted or unsubstituted primary, secondary or tertiary alkyl, that may be cyclic and may be unsaturated; substituted or unsubstituted aryl or heteroaryl; and optionally two or more of the groups R3, R4 and R5 are fused to form a ring;
the group A is selected from the group consisting of a nucleophilic carbene, and a phosphorus ligand independently selected from the list of groups as defined for group Z, with the provisos that;
both groups Z and A are not phosphine and where A is a nucleophilic carbene, Z is not phosphine; and when A is a nucleophilic carbene, Z is not phosphine; and
causing metathesis polymerisation of the monomer, for a time and at a temperature capable of causing metathesis polymerisation.
3. The method according to claim 1 wherein the group A is an N-heterocyclic carbene.
4. The method according to claim 1 wherein the anionic ligands X are independently selected from the group consisting of halogen, benzoate, C1-C5 carboxylates.
5. The method according to claim 1 wherein the groups R1 and R2 are H and aryl.
6. The method according to claim 1 wherein the groups R1 and R2 are fused to form a substituted or unsubstituted indenylidene moiety.
8. The method according to claim 1 wherein the anionic ligands X are independently selected from the group consisting pivalate, trifluoroacetate, C1-C5 alkoxy, phenoxy, C1-C5 alkyl thio, tosylate, mesylate, brosylate, trifluoromethane sulfonate, phenylacetate, and pseudo-halogen.
10. The method according to claim 9 wherein the groups R1 and R2 are fused together to form a ring that may be substituted or unsubstituted, saturated or unsaturated and may be fused to a further ring.
11. The method according to claim 9 wherein the groups R1 and R2 are fused to form a substituted or unsubstituted indenylidene moiety.
12. The method according to claim 9 wherein the group A is an N-heterocyclic carbene.
14. The method according to claim 9 wherein R4 and R5 are aryl.
15. The method according to claim 9 wherein R4 and R5 are phenyl.
16. The method according to claim 9 wherein R3 is selected from the group consisting of substituted or unsubstituted primary alkyl and substituted or unsubstituted aryl.
16. The method according to claim 9 wherein R3 is methyl, ethyl or phenyl.
17. The method of claim 1 , further comprising the steps of:
before the metathesis step, forming a mixture of the monomer and the ruthenium polymerisation catalyst of formula II at a temperature wherein the step of metathesis polymerisation of the monomer is latent; and
subsequently heating the mixture such that the monomer is polymerized.
18. The method of claim 17 , wherein the mixture is introduced into a mold prior to the subsequent heating step such that the mixture conforms to the mold.
19. A ruthenium complex of the formula:
wherein for each occurrence the groups X are the same or different and are anionic ligands or are fused to form a bidentate ligand;
the groups R1 and R2 are fused together to form a ring that may be substituted or unsubstituted, saturated or unsaturated and may be fused to a further ring;
the group Z is
wherein the groups R3, R4 and R5 are each independently for each occurrence selected from the group consisting of substituted or unsubstituted primary, secondary or tertiary alkyl, that may be cyclic and may be unsaturated; substituted or unsubstituted aryl or heteroaryl; and optionally two or more of the groups R3, R4 and R5 are fused to form a ring; and
the group A is a nucleophilic carbene.
20. The complex according to claim 19 wherein the groups R1 and R2 are fused to form a substituted or unsubstituted indenylidene moiety.
21. The complex according to claim 19 wherein group A is an N-heterocyclic carbene.
24. A latent ROMP catalyst composition comprising:
a ruthenium complex of the formula:
wherein for each occurrence the groups X are the same or different and are anionic ligands or are fused to form a bidentate ligand;
the groups R1 and R2 are fused together to form a ring that may be substituted or unsubstituted, saturated or unsaturated and may be fused to a further ring;
the group Z is
wherein the groups R3, R4 and R5 are each independently for each occurrence selected from the group consisting of substituted or unsubstituted primary, secondary or tertiary alkyl, that may be cyclic and may be unsaturated; substituted or unsubstituted aryl or heteroaryl; and optionally two or more of the groups R3, R4 and R5 are fused to form a ring; and
the group A is a nucleophilic carbene; and
one or more of: a solvent; or a monomer comprising at least one olefin and/or alkyne functional group.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/809,205 US20180065914A1 (en) | 2011-09-28 | 2017-11-10 | Ruthenium polymerisation catalysts |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1116719.4 | 2011-09-28 | ||
GBGB1116719.4A GB201116719D0 (en) | 2011-09-28 | 2011-09-28 | Ruthenium polymerisation catalysts |
PCT/GB2012/000744 WO2013045876A1 (en) | 2011-09-28 | 2012-09-28 | Ruthenium polymerisation catalysts |
US201414348407A | 2014-03-28 | 2014-03-28 | |
US15/809,205 US20180065914A1 (en) | 2011-09-28 | 2017-11-10 | Ruthenium polymerisation catalysts |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2012/000744 Continuation WO2013045876A1 (en) | 2011-09-28 | 2012-09-28 | Ruthenium polymerisation catalysts |
US14/348,407 Continuation US9815765B2 (en) | 2011-09-28 | 2012-09-28 | Ruthenium polymerisation catalysts |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180065914A1 true US20180065914A1 (en) | 2018-03-08 |
Family
ID=44994119
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/348,407 Expired - Fee Related US9815765B2 (en) | 2011-09-28 | 2012-09-28 | Ruthenium polymerisation catalysts |
US15/809,205 Abandoned US20180065914A1 (en) | 2011-09-28 | 2017-11-10 | Ruthenium polymerisation catalysts |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/348,407 Expired - Fee Related US9815765B2 (en) | 2011-09-28 | 2012-09-28 | Ruthenium polymerisation catalysts |
Country Status (4)
Country | Link |
---|---|
US (2) | US9815765B2 (en) |
EP (1) | EP3055063A1 (en) |
GB (1) | GB201116719D0 (en) |
WO (1) | WO2013045876A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10501488B2 (en) | 2015-09-24 | 2019-12-10 | Umicore Ag & Co. Kg | Metal carbene olefin metathesis catalysts |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3081572A1 (en) * | 2015-04-16 | 2016-10-19 | ARLANXEO Deutschland GmbH | Ruthenium-or osmium-based complex catalysts |
EP3409697A1 (en) * | 2017-05-28 | 2018-12-05 | SABIC Global Technologies B.V. | Preparation of polymer dispersions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19815275B4 (en) | 1998-04-06 | 2009-06-25 | Evonik Degussa Gmbh | Alkylidene complexes of ruthenium with N-heterocyclic carbene ligands and their use as highly active, selective catalysts for olefin metathesis |
WO2000015339A1 (en) | 1998-09-10 | 2000-03-23 | University Of New Orleans Foundation | Catalyst complex with carbene ligand |
GB201004732D0 (en) * | 2010-03-22 | 2010-05-05 | Univ Aberdeen | Ruthenium complexes for use in olefin metathesis |
-
2011
- 2011-09-28 GB GBGB1116719.4A patent/GB201116719D0/en not_active Ceased
-
2012
- 2012-09-28 WO PCT/GB2012/000744 patent/WO2013045876A1/en active Application Filing
- 2012-09-28 EP EP12780254.4A patent/EP3055063A1/en not_active Withdrawn
- 2012-09-28 US US14/348,407 patent/US9815765B2/en not_active Expired - Fee Related
-
2017
- 2017-11-10 US US15/809,205 patent/US20180065914A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10501488B2 (en) | 2015-09-24 | 2019-12-10 | Umicore Ag & Co. Kg | Metal carbene olefin metathesis catalysts |
Also Published As
Publication number | Publication date |
---|---|
US9815765B2 (en) | 2017-11-14 |
EP3055063A1 (en) | 2016-08-17 |
GB201116719D0 (en) | 2011-11-09 |
WO2013045876A1 (en) | 2013-04-04 |
US20140228563A1 (en) | 2014-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9233994B2 (en) | Ruthenium complexes for use in olefin metathesis | |
Monsaert et al. | Latent olefin metathesis catalysts | |
US6613910B2 (en) | One-pot synthesis of group 8 transition metal carbene complexes useful as olefin metathesis catalysts | |
Fürstner et al. | Cationic ruthenium allenylidene complexes as catalysts for ring closing olefin metathesis | |
Lozano-Vila et al. | Ruthenium-based olefin metathesis catalysts derived from alkynes | |
US8536344B2 (en) | Metathesis catalysts | |
EP2280017B1 (en) | Catalytic complex for olefin metathesis reactions, process for the preparation thereof and use thereof | |
CA2442368C (en) | Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts | |
CA2372746C (en) | Imidazolidine-based metal carbene metathesis catalysts | |
WO2009126831A1 (en) | Ruthenium olefin metathesis catalysts bearing n-heterocyclic carbene ligands with substituted backbone | |
PL207783B1 (en) | Ruthenium complexes as (pre)catalysts for metathesis reactions | |
Leitgeb et al. | A latent ruthenium based olefin metathesis catalyst with a sterically demanding NHC ligand | |
JP2018123164A (en) | Ruthenium-based metathesis catalysts, precursors for their preparation and their use | |
EP3865495B1 (en) | Ruthenium complexes useful for catalyzing metathesis reactions | |
EP2639219B1 (en) | Ruthenium-based metathesis catalysts and precursors for their preparation | |
US20180065914A1 (en) | Ruthenium polymerisation catalysts | |
Dorta et al. | Cross metathesis allowing the conversion of a ruthenium indenylidene complex into Grubbs' catalyst | |
Farrell et al. | Synthesis, isomerization, and catalytic transfer hydrogenation activity of rhodium (III) complexes containing both chelating dicarbenes and diphosphine ligands | |
Despagnet-Ayoub et al. | N-Heterocyclic carbenes as ligands for olefin metathesis catalysts | |
Balof et al. | Olefin metathesis catalysts bearing a pH-responsive NHC ligand: a feasible approach to catalyst separation from RCM products | |
EP2104566B1 (en) | Olefin metathesis initiators bearing thiazol-2-ylidene ligands | |
Siano et al. | Activity and stereoselectivity of Ru-based catalyst bearing a fluorinated imidazolinium ligand | |
US9586981B2 (en) | Z-selective metathesis catalysts | |
Urbina‐Blanco et al. | Ruthenium‐Indenylidene and Other Alkylidene Containing Olefin Metathesis Catalysts | |
Dixneuf et al. | Ruthenium indenylidene catalysts for alkene metathesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS, Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CAZIN, CATHERINE;REEL/FRAME:044094/0511 Effective date: 20140416 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |